Electrosurgical system

Information

  • Patent Grant
  • 11696796
  • Patent Number
    11,696,796
  • Date Filed
    Tuesday, November 5, 2019
    4 years ago
  • Date Issued
    Tuesday, July 11, 2023
    11 months ago
Abstract
An electrosurgical system is provided and includes a bipolar electrosurgical instrument and an electrosurgical generator. The bipolar electrosurgical instrument is arranged to seal and cut tissue captured between jaws of the bipolar electrosurgical instrument. The electrosurgical generator is arranged to supply RF energy through the bipolar electrosurgical instrument, monitor the supplied RF energy, and adjust or terminate the supplied RF energy to optimally seal the tissue.
Description
BACKGROUND

The present application relates generally to electrosurgical systems and methods. More particularly, the present application relates to electrosurgical generators and associated instruments for sealing and cutting tissue.


There are available electrosurgical devices or instruments that use electrical energy to perform certain surgical tasks. Typically, electrosurgical instruments are surgical instruments such as graspers, scissors, tweezers, blades, and/or needles that include one or more electrodes that are configured to be supplied with electrical energy from an electrosurgical generator. The electrical energy can be used to coagulate, fuse, or cut tissue.


Electrosurgical instruments typically fall within two classifications: monopolar and bipolar. In monopolar instruments, electrical energy is supplied to one or more electrodes on the instrument with high current density while a separate return electrode is electrically coupled to a patient. The separate return electrode is often designed to minimize current density. Monopolar electrosurgical instruments can be useful in certain procedures but can include a risk of certain types of issues such as electrical burns that may be partially attributable to the functioning of the return electrode.


In bipolar electrosurgical instruments, one or more electrodes are electrically coupled to a source of electrical energy of a first polarity. In addition, one or more other electrodes are electrically coupled to a source of electrical energy of a second polarity opposite the first polarity. Bipolar electrosurgical instruments, which operate without separate return electrodes, can deliver electrical signals to a focused tissue area with reduced risks compared to monopolar electrosurgical instruments.


Even with the relatively focused surgical effects of bipolar electrosurgical instruments surgical, however, outcomes are often highly dependent on surgeon skill. For example, thermal tissue damage and necrosis can occur in instances where electrical energy is delivered for a relatively long duration or where a relatively high-powered electrical signal is delivered even for a short duration. The rate at which a tissue will achieve the desired fusing, sealing, or cutting effect upon the application of electrical energy varies based on the tissue type and can also vary based on pressure applied to the tissue by an electrosurgical device. However, it can be difficult for a surgeon to assess how quickly a mass of combined tissue types grasped in an electrosurgical instrument will be sealed a desirable amount.


SUMMARY OF THE INVENTION

Disclosed herein are methods, devices, and systems for fusing or sealing tissue. In a first embodiment, a method for fusing or sealing tissue is described. The method begins by first applying a first amount of RF energy to an area of tissue. A desiccation level of the area of tissue affected by the first amount of RF energy is then determined. Based on the determined desiccation level, the amount of RF energy is reduced to a second amount. Subsequent to reducing to the second amount of RF energy, an increasing amount of RF energy is applied to the area of tissue until a third amount is reached. A rate by which the RF energy is added and the third amount is based on the determined desiccation level. The third amount of RF energy is applied to the area of tissue for a pre-determined period of time. Once the pre-determined period of time has elapsed, the application of the RF energy to the area of tissue is terminated.


In another embodiment, an electrosurgical generator used for fusing or sealing tissue is described. The electrosurgical generator includes a controller and an RF amplifier that generates a corresponding amount of RF energy based on the instructions provided by the controller. The controller first instructs the RF amplifier to apply a first amount of RF energy to an area of tissue. The controller then determines a desiccation level of the area of tissue affected by the first amount of RF energy. The controller then instructs the RF amplifier to first reduce the amount of RF energy to a second amount based on the determined desiccation level and subsequently increase an amount of RF energy being applied to the area to a third amount. A rate by which the RF energy is added and the third amount is based on the determined desiccation level. The controller instructs the RF amplifier to maintain the third amount of RF energy being applied to the area of tissue for a pre-determined period of time. Once the pre-determined period of time has elapsed, the controller instructs the RF amplifier to terminate the application of the RF energy to the area of tissue.


In another embodiment, a system for fusing or sealing tissue is described. The system includes an electrosurgical generator that generates RF energy and an electrosurgical instrument that fuses or seals an area of tissue. The electrosurgical instrument receives the RF energy from the electrosurgical generator in order to fuse or seal the area of tissue. The amount of RF energy that is generated and provided to the electrosurgical instrument to use in the fusing or sealing of the area of tissue is based on a determined desiccation level of the area of tissue.





BRIEF DESCRIPTION OF THE DRAWINGS

In order to describe the manner which, the above-recited and other advantages and features of the disclosure can be obtained, a more particular description of the principles briefly described above will be rendered by reference to specific embodiments that are illustrated in the appended drawings. Understanding that these drawings depict only embodiments of the disclosure and are not therefore to be considered to be limiting of its scope, the principles herein are described and explained with additional specificity and detail through the use of the accompanying drawings in which the reference numerals designate like parts throughout the figures thereof.



FIG. 1 is a perspective view of an electrosurgical system in accordance with various embodiments of the present invention.



FIG. 2 and FIG. 3 are perspective views of an electrosurgical instrument in accordance with various embodiments of the present invention.



FIG. 4 to FIG. 7 are graphical representations of samples of experimental data for a sealing process or aspects thereof with an electrosurgical system in accordance with various embodiments of the present invention.



FIG. 8 is a schematic block diagram of portions of an electrosurgical system in accordance with various embodiments of the present invention.



FIG. 9 is a graphical representation of samples of experimental data for a sealing process or aspects thereof with an electrosurgical system in accordance with various embodiments of the present invention.



FIG. 10 is a flowchart illustrating operations of an electrosurgical system in accordance with various embodiments of the present invention.





DETAILED DESCRIPTION OF THE INVENTION

In accordance with various embodiments, an electrosurgical instrument is provided that is configured to fuse and cut tissue. In various embodiments, the electrosurgical device or instrument includes a first jaw and a second jaw. The second jaw opposes the first jaw to facilitate the grasping of tissue between the first jaw and the second jaw. Both the first jaw and the second jaw include an electrode. The electrodes of the first jaw and the second jaw are arranged to seal tissue grasped between the first jaw and the second jaw using radio frequency (RF) energy.


In accordance with various embodiments, an electrosurgical system for sealing tissue is also provided. The electrosurgical system in various embodiments comprises an electrosurgical generator and an electrosurgical instrument or device. The electrosurgical generator includes an RF amplifier and a controller. The RF amplifier supplies RF energy through a removably coupled electrosurgical instrument configured to seal tissue with only RF energy. The controller and/or RF sense are arranged to monitor and/or measure the supplied RF energy and/or components thereof. In various embodiments, the controller signals the RF amplifier to adjust, e.g., increase, hold, decrease and/or stop, voltage of the supplied RF energy at predetermined points or conditions of a sealing cycle. In various embodiments, the controller signals the RF amplifier to halt the supplied RF energy or initiate termination of the supplied RF energy from the RF amplifier.


The various features and embodiments provided throughout can be used alone, or in combination with other features and/or embodiments other than as expressly described and although specific combinations of embodiments and features or aspects of various embodiments may not be explicitly described such combinations however are contemplated and within the scope of the present inventions. Many of the attendant features of the present inventions will be more readily appreciated as the same becomes better understood by reference to the foregoing and following description and considered in connection with the accompanying drawings.


Generally, an electrosurgical system is provided that includes an electrosurgical generator and a removably coupled electrosurgical instrument that are configured to optimally seal or fuse tissue. The RF energy is supplied by the electrosurgical generator that is arranged to provide the appropriate RF energy to seal the tissue. The electrosurgical generator, in accordance with various embodiments, determines the appropriate RF energy and the appropriate manner to deliver the RF energy for the particular connected electrosurgical instrument, the particular tissue in contact with the electrosurgical instrument, and/or a particular surgical procedure being performed. Operationally, RF sealing or fusing of tissue between the jaws is provided to decrease sealing time and/or thermal spread.


In accordance with various embodiments, the electrosurgical system comprises a dynamic pulse system arranged to control and shut off RF energy delivery that results in an optimal balance of hemostasis reliability, seal time, and tissue adherence for a wide range of tissues. In various embodiments, the electrosurgical system comprises a double or repeat seal system arranged to reduce the application of RF energy for multiple activations to reduce eschar (sealed tissue debris) buildup, tissue adherence, and thermal spread for tissue that is already sealed.


Referring to both FIG. 1 and FIG. 2, an exemplary embodiment of the electrosurgical system is illustrated. The electrosurgical system includes an electrosurgical generator 10 (as illustrated in FIG. 1) and a removably connectable electrosurgical instrument 20 (as illustrated in FIG. 2). The electrosurgical instrument 20 can be electrically coupled to the electrosurgical generator 10 via a cabled connection 30 having an adaptor 32 configured to connect to a tool or device port 12 on the electrosurgical generator 10. The electrosurgical instrument 20 may include audio, tactile and/or visual indicators to apprise a user of a particular predetermined status of the electrosurgical instrument 20 such as a start and/or end of a fusion or cut operation. In other embodiments, the electrosurgical instrument 20 can be reusable and/or connectable to another electrosurgical generator for another surgical procedure. In some embodiments, a manual controller such as a hand or foot switch can be connectable to the electrosurgical generator 10 and/or electrosurgical instrument 20 to allow predetermined selective control of the electrosurgical instrument 20 such as to commence a fusion or cut operation.


In accordance with various embodiments, the electrosurgical generator 10 is configured to generate radio frequency (RF) electrosurgical energy and to receive data or information from the electrosurgical instrument 20 electrically coupled to the electrosurgical generator 10. The electrosurgical generator 10, in one embodiment, outputs RF energy (e.g., 375VA, 150V, 5 A at 350 kHz) and in one embodiment is configured to measure current and/or voltage of the RF energy and/or to calculate power of the RF energy or a phase angle or difference between RF output voltage and RF output current during activation or supply of the RF energy. The electrosurgical generator 10 regulates voltage, current and/or power and monitors the RF energy output (e.g., voltage, current, power and/or phase). In one embodiment, the electrosurgical generator 10 stops the RF energy output under predefined conditions such as when a device switch is de-asserted (e.g., fuse button released), a time value is met, and/or active phase angle, current, voltage or power and/or changes thereto is greater than, less than or equal to a stop value, threshold or condition and/or changes thereto.


As illustrated in FIG. 1, the electrosurgical generator 10 comprises at least one advanced bipolar tool port 12, a standard bipolar tool port 16, and an electrical power port 14. In other embodiments, electrosurgical units can comprise different numbers of ports. For example, in some embodiments, an electrosurgical generator 10 can comprise more or fewer than two advanced bipolar tool ports, more or fewer than the standard bipolar tool port, and more or fewer than the power port. In one embodiment, the electrosurgical generator 10 comprises only two advanced bipolar tool ports.


In accordance with various embodiments, each advanced bipolar tool port 12 is configured to be coupled to an advanced electrosurgical instrument having an attached or integrated memory module. The standard bipolar tool port 16 is configured to receive a non-specialized bipolar electrosurgical tool that differs from the advanced bipolar electrosurgical instrument connectable to the advanced bipolar tool port 12. The electrical power port 14 is configured to receive or be connected to a direct current (DC) accessory device that differs from the non-specialized bipolar electrosurgical tool and the advanced electrosurgical instrument. The electrical power port 14 is configured to supply direct current voltage. For example, in some embodiments, the electrical power port 14 can provide approximately 12 Volts DC. The electrical power port 14 can be configured to power a surgical accessory, such as a respirator, pump, light, or another surgical accessory. Thus, in addition to replacing the electrosurgical generator 10 for standard or non-specialized bipolar tools, the electrosurgical generator 10 can also replace a surgical accessory power supply. In some embodiments, replacing presently-existing generators and power supplies with the electrosurgical generator 10 can reduce the amount of storage space required on storage racks cards or shelves and reduce the number of main power cords required in a surgical workspace.


In accordance with various embodiments, the electrosurgical generator 10 can comprise a display 15. The display 15 can be configured to indicate the status of the electrosurgical system including, among other information, the status of the one or more electrosurgical instruments and/or accessories, connectors or connections thereto.


The electrosurgical generator 10 in accordance with various embodiments can comprise a user interface, such as a plurality of buttons 17. The plurality of buttons 17 can allow user interaction (e.g., receiving user input) with the electrosurgical generator 10 such as, for example, requesting an increase or decrease in the electrical energy supplied to one or more electrosurgical instruments coupled to the electrosurgical generator 10. In other embodiments, the display 15 can be a touch screen display thus integrating data display and user interface functionalities. In one embodiment, the electrosurgical tool or instrument 20 can further comprise of one or more memory modules. In some embodiments, the memory comprises operational data concerning the electrosurgical instrument and/or other instruments. For example, in some embodiments, the operational data may include information regarding electrode configuration/reconfiguration, the electrosurgical instrument uses, operational time, voltage, power, phase and/or current settings, and/or particular operational states, conditions, scripts, processes or procedures. In one embodiment, the electrosurgical generator 10 can initiate reads and/or writes to the memory module.


In accordance with various embodiments, the electrosurgical generator 10 provides the capability to read the phase difference or phase angle between the voltage and current of the RF energy sent through the connected electrosurgical instrument 20 while RF energy is active. While tissue is being fused, phase readings are used to detect different states during the fuse or seal and cut process.


The electrosurgical generator 10 in accordance with various embodiments monitors, measures or calculates current, power, impedance or phase of the RF output, but does not control current, power, impedance or phase. The electrosurgical generator 10 regulates voltage and can also adjust voltage. Electrosurgical power delivered is a function of applied voltage, current, and tissue impedance. The electrosurgical generator 10, through the regulation of voltage, can affect the electrosurgical power, RF output, or energy being delivered. Power reactions are caused by the power interacting with the tissue or the state of the tissue without any control by a generator other than by the generator supplying power.


Once the electrosurgical generator 10 starts to deliver electrosurgical power, the electrosurgical generator 10 continues to do so continuously, e.g., for 150 ms, until a fault occurs or until a specific parameter is reached. In one example, the jaws of the electrosurgical instrument can be opened and thus compression relieved at any time before, during, and after the application of electrosurgical power. The electrosurgical generator 10, in one embodiment, also does not pause or wait a particular duration or a predetermined time delay to commence termination of the electrosurgical energy.


With additional reference to FIG. 3, in accordance with various embodiments, a bipolar electrosurgical instrument 20 is provided. In the illustrated embodiment, the bipolar electrosurgical instrument 20 includes an actuator 24 coupled to an elongate rotatable shaft 26. The elongate rotatable shaft 26 has a proximal end and a distal end defining a central longitudinal axis therebetween. At the distal end of the elongate rotatable shaft 26 are jaws 22 and at the proximal end is the actuator 24. In one embodiment, the actuator 24 is a pistol-grip like handle.


The actuator 24 includes a movable handle 23 and a stationary handle or housing 28. The movable handle 23 is coupled and movable relative to the stationary housing 28. In accordance with various embodiments, the movable handle 23 is slidably and pivotally coupled to the stationary housing 28. In operation, the movable handle 23 is manipulated by a user, e.g., a surgeon, to actuate the jaws, for example, selectively opening and closing the jaws 22.


In accordance with various embodiments, the actuator 24 includes a latch mechanism to maintain the movable handle 23 in a second position with respect to the stationary housing 28. In various embodiments, the movable handle 23 comprises a latch arm which engages a matching latch contained within the stationary handle or housing 28 for holding the movable handle 23 at a second or closed position. The actuator 24 in various embodiments also comprises a wire harness that includes insulated individual electrical wires or leads contained within a single sheath. The wire harness can exit the stationary housing 28 at a lower surface thereof and form part of the cabled connection 30 (as illustrated in FIG. 2). The wires within the harness can provide electrical communication between the electrosurgical instrument 20 and the electrosurgical generator 10 and/or accessories thereof.


In various embodiments, a switch is connected to a user manipulated activation button 29 and is activated when the activation button 29 is depressed. In one aspect, once activated, the switch completes a circuit by electrically coupling at least two leads together. As such, an electrical path is then established from an electrosurgical generator 10 to the actuator 24 to supply RF energy to the electrosurgical instrument 20. In various embodiments, the electrosurgical instrument 20 comprises a translatable mechanical cutting blade that can be coupled to a blade actuator such as a blade lever or trigger 25 of the actuator 24. The mechanical cutting blade is actuated by the blade trigger 25 to divide the tissue between the jaws 22.


In one embodiment, the actuator 24 includes an elongate rotatable shaft 26 assembly that includes a rotation knob 27 which is disposed on an outer cover tube of the elongate rotatable shaft 26. The rotation knob 27 allows a surgeon to rotate the elongate rotatable shaft 26 of the electrosurgical instrument 20 while gripping the actuator 24. In accordance with various embodiments, the elongate rotatable shaft 26 comprises an actuation tube coupling the jaws 22 with the actuator 24.


Attached to the distal end of the elongate rotatable shaft 26 are jaws 22 that comprise a first or upper jaw 31 and a second or lower jaw 33. In one embodiment, a jaw pivot pin pivotally couples the first jaw 31 and the second jaw 33 and allows the first jaw 31 to be movable and pivot relative to the second jaw 33. In various embodiments, one jaw is fixed with respect to the elongate rotatable shaft 26 such that the opposing jaw pivots with respect to the fixed jaw between an open and a closed position. In other embodiments, both the first jaw 31 and the second jaw 33 can be pivotally coupled to the elongate rotatable shaft 26 such that both the first jaw 31 and the second jaw 33 can pivot with respect to each other.


The first or upper jaw 31 includes an electrode plate or pad. Similarly, the second or lower jaw 33 also includes an electrode plate or pad. The electrode of the first or upper jaw 31 and the electrode of the second or lower jaw 33 are electrically coupled to the electrosurgical generator 10 via wires and connectors to supply RF energy to tissue grasped between the electrodes of the first jaw 31 and the second jaw 33. The electrodes, as such, are arranged to have opposing polarity and to transmit the RF energy therebetween. The first or upper jaw 31 in various embodiments also includes an upper jaw support with an assembly spacer positioned between the upper jaw support and the electrode. The first or upper jaw 31 also includes an overmold or is overmolded. The second or lower jaw 33 can also include a lower jaw support and the electrode. In the illustrated embodiment, the electrode is integrated or incorporated in the lower jaw support and thus the lower jaw support and the electrode form a monolithic structure and electrical connection. A blade channel extends longitudinally along the length of the first or upper jaw 31, the second or lower jaw 33, or both through which the blade operationally traverses. Surrounding a portion of the blade channel are one or more conductive posts. The conductive posts assist in immobilizing the tissue to be cut. The conductive posts also assist in ensuring the tissue being cut adjacent or proximate to the blade channel is fused as the conductive posts also participate in the transmission of RF energy to the tissue grasped between the jaws 22. The second or lower jaw 33 can also include an overmold or is overmolded.


In accordance with various embodiments, the electrodes have a generally planar sealing surface arranged to contact and compress tissue captured between the jaws 22. The electrodes of the first or upper jaw 31 and second or lower jaw 33 in various embodiments have a seal surface in which the width of the seal surface is uniform, constant, or remains unchanged throughout.


In various embodiments, the jaws 22 are curved to increase visualization and mobility of the jaws 22 at the targeted surgical site and during the surgical procedure. The jaws 22 have a proximal elongate portion that is denoted or aligned with straight lines and a curved distal portion denoting or defining a curve that is connected to the straight lines. In various embodiments, the proximal most portion of the proximal elongate portion has or delimits a diameter that equals or does not exceed a maximum outer diameter of the jaws 22 or elongate rotatable shaft 26. The jaws 22 in various embodiments have a maximum outer diameter in which the proximal most portion of the jaw 22 and the distal most portion of the jaws 22 remains within the maximum outer diameter. The curved distal potion has or delimits a diameter that is smaller than the maximum outer diameter and the diameter of the proximal most portion of the proximal elongate portion. In various embodiments, the jaw 22 has a deeper inner curve cut-out than the outer curve and in various embodiments the tip of the jaws 22 are tapered for blunt dissection. The jaws 22 include a blade channel having an proximal elongate channel curving to a distal curved channel in which the proximal elongate channel is parallel and offset to the longitudinal axis of the elongate rotatable shaft 26 of the electrosurgical instrument 20. As such, visibility and mobility at the jaws 22 are maintained or enhanced without increasing jaw dimensions that may further reduce the surgical working area or require larger access devices or incisions into the patient's body.


In some embodiments, electrode geometry of the conductive pads of the jaw assembly ensures that the sealing area or surface completely encloses the distal portion of the cutting path. In accordance with various embodiments, the dimensions of the jaw surfaces are such that it is appropriately proportioned with regards to the optimal pressure applied to the tissue between the jaws 22 for the potential force the force mechanism can create. Its surface area is also electrically significant with regards to the surface area contacting the tissue. This proportion of the surface area and the thickness of the tissue have been optimized with respect to its relationship to the electrical relative properties of the tissue.


In various embodiments, the second or lower jaw 33 and an associated conductive pad have an upper outer surface arranged to be in contact with tissue. The upper surfaces are angled or sloped and mirror images of each other with such positioning or orientation facilitating focused current densities and securement of tissue. In various embodiments, the second or lower jaw 33 is made of stainless steel and is as rigid as or more rigid than the conductive pad. In various embodiments, the second or lower jaw 33 comprises rigid insulators made of a non-conductive material and are as rigid as or more rigid than the second or lower jaw 33 or the conductive pad. In various embodiments, the second or lower jaw 33 and the conductive pad are made of the same material.


In accordance with various embodiments, the RF energy control process or system supplies RF energy and controls the supplied RF energy to seal or fuse tissue. At the beginning of a seal cycle, the system is arranged to apply RF energy having a quickly increasing voltage. As such, the system provides RF energy having voltage that increases over a minimal time period resulting in the supplied RF energy with a voltage profile having a steep slope or change rate. In accordance with various embodiments, the system seeks to continue to increase voltage of the RF energy to identify or determine an RF output peak condition. In accordance with various embodiments, the RF output peak condition is denoted by a maximum current or power value resulting from the increasing voltage of the supplied RF energy. In various embodiments, the system seeks to increase voltage of the supplied RF energy up to and/or equal to this RF output peak condition. However, determining this RF output peak condition or point can vary based on tissue type and/or tissue volume in contact with the electrode or electrodes of the electrosurgical instrument. As such, the high voltage ramp or pulse provided by the system has a duration that is variable based on the tissue in contact with the instrument rather than a static, fixed, or predefined value, as exemplified in FIG. 4. Similarly, electrode size and electrode contact relative to the tissue can further cause variations in this RF output peak condition. As such, determination of the RF output peak condition can be difficult.


With the system seeking to reach this varying RF output peak condition, the amount of time the system or electrosurgical generator supplies RF energy can also vary. For example, as shown in FIG. 5, the peak conditions 121 occur at different times with tissue of different volumes. For example, tissue with smaller volumes may experience their respective peak conditions much earlier within a seal cycle compared to tissue that may have a much larger volume (e.g., as late as 1250 ms into a seal cycle). As such, the peak condition in various embodiments generally happens later for thicker tissue, as thicker tissues may take longer to heat up. Furthermore, the height of the peak can be determined by the surface area of the tissue. Tissues with larger surface areas may have higher peak values due to having more tissue being or acting as electrically parallel resistance. In various embodiments, however, the amount of time for quickly increasing the voltage of the RF energy being applied to the tissue is limited to a set maximum time threshold or limit and as a result avoids applying the RF energy longer than necessary. Setting a static time without seeking to reach the RF output peak condition however can lead to applying the RF energy longer than necessary, particularly for small tissue volumes. Furthermore, the use of static times can also present the situation where applying RF energy may not be long enough, particularly for large tissue volumes.


Accordingly, in accordance with various embodiments, providing a dynamic voltage ramp balances system performance on each end and allows for a close-to-ideal or optimal RF energy dosage initially or early and ultimately resulting in optimal tissue sealing. Rapidly achieving this RF output peak condition optimizes overall sealing of tissue and reduces time to seal without losing or reducing tissue integrity. In accordance with various embodiments, the electrosurgical generator initially adjusts the voltage of the RF energy to be relatively high (e.g., 40% or greater than the maximum voltage) and increases the voltage of the RF energy quickly (e.g., at a rate 10 volts per millisecond) to provide this dynamic voltage ramp or pulse to achieve the RF output peak condition.


Using a dynamic ramp ensures any tissue, regardless of volume, for example, is brought to the same RF output peak condition or water vaporization point quickly. As such, the likelihood of failing to reach or maintain the water vaporization point of the tissue (under-pulsing) is reduced. By reducing the likelihood of under-pulsing, the average RF delivery after the pulse can be shortened in time or lowered in power without affecting seal quality. Furthermore, the focus or attention of the system can be directed to removing water from the tissue efficiently, rather than variability associated with heating tissue.


As previously noted, determining when the RF output peak condition occurs is difficult, particularly in real-time. Noise or similar fluctuations or imprecision in measurement of the RF output may obscure or delay the determination of the RF output peak condition. Smoothing or filtering out such imprecisions, in various embodiments, can assist in enhancing detection or determination of the RF output peak condition. Delays in filter processing and the like in various embodiments may however also delay the determination of the RF output peak condition. Delays in identifying the determination of the RF output peak condition can cause the system to over-pulse the tissue.


In accordance with various embodiments, to avoid or reduce this delay in identifying the RF output peak condition or a potential over-pulse of the tissue, the system can provide a break system. The break system utilizes a break value defined based on a predicted maximum value or window representing the RF output peak condition. In various embodiments, the break value is as a percentage of the predicted maximum and/or a static threshold or gap, e.g., 400 mA or 30 W, below or within a predicted maximum value or window. The system monitors the RF output, e.g., the current and/or power, and the break system ensures that the monitored current and/or power reaches this break value before the voltage is adjusted, e.g., dropped, to ensure the RF output peak condition is quickly and accurately identified, thereby balancing both interests. It is however recognized that the lower or greater offset of the break value below the predicted maximum, the longer the specifically high voltage of the RF output is applied, e.g., over-pulse, but the less likely the system is to prematurely halt or drop the voltage of the RF output, e.g., under-pulse, due to for example triggering on noise.


In various embodiments, the system records or stores a predicted maximum value and looks for the next monitored value to exceed the stored predicted maximum value. When this occurs, the monitored value is stored as the “new” maximum value. In various embodiments, the system monitors or records the RF output at set intervals, such as every 50 ms, and compares the interested value of the RF output against the stored predicted maximum value to determine if a new maximum has occurred.


In accordance with various embodiments, the system utilizes a series of states with exit conditions set at regular intervals. As RF energy is applied and the value of interest changes, e.g., power and/or current increases, states are progressed through or cascaded. By increasing the number of states, the resolution of the cascade increase. However, depending on the resolution of the cascade, some accuracy can be lost in determining the RF output peak condition. A cascade or similar progression of states however is computationally less intensive and does not require or minimize the use of variables.


In accordance with various embodiments, the break value or range is calculated from a predicted maximum value by multiplying the predicted value by a percentage, e.g., 80%. Higher predicted maximums could require a larger drop in the interested value (e.g., current or power) to trigger or to identify the RF output peak condition. A break value or range in various embodiments is calculated from the predicted maximum value and subtracting a static offset (e.g., 400 mA or 30 W). Depending on the predicted maximum, this can be result in smaller or larger values than a percentage calculation but can be useful when the amplitude of noise or similar imprecision in the system is known, as the offset can be set to account for the imprecision (e.g., set higher than the amplitude of the noise). To ensure that a peak is detectable, the interested value (e.g., current or power) can be checked against the break value—in some scenarios the interested value (e.g., current or power) must reach at least the break value prior to any adjustments to the voltage to ensure that a peak can be identified. In various embodiments, the system provides a combination of the offset and percentage acting in parallel or serially and/or varying the order to enhance the identification or determination of the RF output peak condition to, for example, account for known imprecisions or when the predicted maximum value reaches a specific threshold where a larger drop in the interested value to trigger is not desired.


In various embodiments, the system monitors a rate of change of the interested value (e.g., current and/or power) to determine or to anticipate the RF output condition. As such, the system monitors the derivative or rate of the interested value and a change (e.g., a reduction in the change or rate) to identify the RF output peak condition or an indication that the RF output peak condition is near or close to occurring.


In various embodiments, the system is arranged to adjust the current of the RF output to determine the RF output peak condition. In particular, the system, e.g., the RF amplifier of the generator, gradually ramps up current of the supplied RF energy and the generator is placed in current regulation. When a current regulation value exceeds the tissue's ability to take more current, the system will no longer be current regulated, resulting in a sharp increase in voltage as the system switches regulation. This voltage condition is thus used as an indication or determination of the RF output peak condition. As such, this system regulation can forgo the use of a predicted maximum value of interest being stored or utilized as provided in the percentage or offset systems or processes.


In various embodiments, if errors or an unexpected result occurs, the system terminates the process, e.g., the supplying of the RF energy. In various embodiments, such errors comprise a short detection error or open detection error. In one embodiment, a short detection error is determined by the electrosurgical generator when a measured phase angle of the supplied RF energy by the electrosurgical generator equals or exceeds a predetermined value, e.g., sixty degrees. In one embodiment, an open detection error is determined by the electrosurgical generator when a measured current of the supplied RF energy equals or is below a predetermined value, e.g., 100 milliamps, and/or a measured voltage of the supplied RF energy equals or exceeds a predetermined value, e.g., 50 volts. Completion of the control process without errors indicates a successful tissue seal. A successful tissue seal in accordance with various embodiments is recognized as the tissue seal being able to withstand a predetermined range of burst pressures or a specific threshold pressure.


In accordance with various embodiments, it has been identified that tissue seal formation is dependent on denaturization and cross linkage of the native collagen present in vasculature extra cellular matrix which starts at about 60° C. The strength of this matrix is highly dependent on desiccation (or removal of moisture) at the seal site via vaporization of the water present in the sealed tissue. Additionally, at a temperature of at least 80° C., bonds between the denatured collagen and other living tissues can be created. Furthermore, that collagen degrades in response to duration under elevated temperature rather than the peak temperature of exposure. As such, exposing tissue to high temperature conditions (e.g., 100° C.) for the duration of a relatively short seal cycle does not impact the structure of the collagen but allows for the vaporization of water. The total time to seal tissue, in accordance with various embodiments, is reliant on heating the structure to the high temperature, e.g., 100° C., to vaporize water such that the denatured collagen crosslinks and bonds to tissue and to limit collagen-water hydrogen bonding. To optimize seal time, it was therefore found to be desirable to achieve 100° C. within the grasped tissue as quickly as possible to begin the desiccation process.


As such, in accordance with various embodiments, after RF energy has been initiated and/or various device checks are performed, the electrosurgical generator employs through the supplied RF energy a dynamic voltage ramp. Once the dynamic voltage ramp is complete, the system reduces the voltage to a predetermined level and slowly ramps up the voltage of the supplied RF energy. While the ramp occurs, sufficient amount of power is applied to the tissue to maintain a temperature sufficient for desiccation. This allows for continuous vaporization at a rate that does not cause seal structural failures and enhances vessel sealing performance.


In an embodiment, the application of high voltage levels may cause the sealed tissue to adhere to the active electrodes. As such, termination of the voltage ramp at a lower peak voltage and holding that voltage output constant at the end allows for continued energy application while reducing the potential for tissue adherence to the active electrodes. Determination of when to terminate the voltage ramp, in accordance with various embodiments, is conducted by monitoring the phase and current of the supplied RF energy. As the tissue desiccates, the phase will become more capacitive and will draw less current. By terminating the voltage ramp at a fixed current value as it falls and when the phase is capacitive, the desiccation level of the tissue can be categorized. This variable voltage set point allows the seal cycle to adjust the energy application based on electrical and structural differences in tissues being sealed.


In various embodiments, in order to achieve the appropriate tissue effect, the phase angle, current, and/or power of the applied RF energy are measured, calculated, and/or monitored. FIG. 4 to FIG. 7 provide graphical representations of exemplary seal cycles in accordance with various embodiments. As illustrated in FIG. 7, voltage 111a is shown relative to other RF output readings or indicators such as power 111b, impedance 111c, energy 111d, current 111e, and phase 111f. Additionally, although shown in FIG. 4 to FIG. 7, in various embodiments, the electrosurgical generator can be configured to not measure or not calculate one or more of the indicators or readings (e.g., impedance) to reduce operational and power costs and consumptions, and/or reduce the number of parts of the electrosurgical generator. The additional information or readings are generally provided or shown for contextual purposes. Additionally, in various embodiments, impedance or temperature readings may not be used or may not be measured being that such readings may be imprecise or impractical.


As shown in FIG. 7, the voltage of the RF output 111a is increased in the initial moments of the seal cycle and for a period relatively short compared to the total seal time to generate the voltage ramp or pulse of RF energy 131 (illustrated in FIG. 6). In accordance with various embodiments, the system seeks to determine or reach the RF output peak condition 121. Subsequently after reaching the RF output peak condition 121, the voltage of the RF energy is reduced and ramped up, slowly, relative to the voltage pulse. In various embodiments, the slow voltage ramp 132 by the system seeks to maintain the tissue between the jaws close to at least 100° C. and thereby control the boiling rate of water in the tissue. In accordance with various embodiments, in order to achieve the appropriate tissue effect of sealing the tissue, the phase angle, current, and power of the applied RF energy are monitored. Voltage of the RF energy is then held constant 133 to reduce the potential for tissue adherence. At seal completion (e.g., within a predetermined time frame or period according to the system), the RF energy supplied by the system is terminated or the RF energy supply is halted, disrupted, or stopped 134. In various embodiments, the voltage ramp of the RF energy is terminated and after a predefined time period according to the system, the RF energy supplied by the system is terminated or the RF energy supply is halted, disrupted, or stopped.


In various embodiments, the system identifies unintended current draw provided, for example, in some tissue bundles that draw the maximum current or power that can be supplied by the generator. While the system is under such a current condition, the supply of RF energy required to seal the tissue may not be sufficient or be efficiently supplied by the system. In various embodiments, to handle such a condition, the system determines if the current of the RF energy output is greater than 90% of the allowable maximum current, e.g., 4500 mA. If so, the system waits or delays further to ensure that the current has sufficiently dropped thereby indicating that sufficient desiccation of the tissue has occurred. If, after such a delay, the current has not sufficiently dropped, an error is indicated and/or the RF energy being supplied is halted. In accordance with various embodiments, the system determines or confirms that the current has sufficiently dropped if the current falls below a current threshold, e.g., 4100 mA. As such, the system determines that the current condition has ceased and/or the tissue reached a vaporization or peak condition.


Referring now to FIG. 8, in one embodiment, the electrosurgical generator 10 is connected to AC main input and a power supply 41 converts the AC voltage from the AC main input to DC voltages for powering various circuitry of the electrosurgical generator 10. The power supply also supplies DC voltage to an RF amplifier 42 that generates RF energy. In one embodiment, the RF amplifier 42 converts 100 VDC from the power supply to a sinusoidal waveform with a frequency of 350 kHz which is delivered through a connected electrosurgical instrument or tool 20. RF sense circuitry 43 measures/calculates voltage, current, power, and phase at the output of the electrosurgical generator 10 in which RF energy is supplied to the connected electrosurgical instrument or tool 20. The measured/calculated information is supplied to a controller 44.


In one embodiment, the RF sense 43 analyzes the measured AC voltage and current from the RF amplifier 42 and generates DC signals for control signals including voltage, current, power, and phase that are sent to the controller 44 for further processing. In one embodiment, RF sense 43 measures the output voltage and current and calculates the root means square (RMS) of the voltage and current, apparent power of the RF output energy, and the phase angle between the voltage and current of the RF energy being supplied through the connected electrosurgical instrument or tool 20. In particular, the voltage and current of the output RF energy are processed by analog circuitry of the RF sense to generate real and imaginary components of both voltage and current. These signals are processed by a field-programmable gate array (FPGA) to give different measurements relating to voltage and current, including the RMS measurements of the AC signals, phase shift between voltage and current, and power. Accordingly, in one embodiment, the output voltage and current are measured in analog, converted to digital, processed by an FPGA to calculate RMS voltage and current, apparent power and phase angle between voltage and current, and then are converted back to analog for the controller 44.


In one embodiment, controller 44 controls or signals the RF amplifier 42 to affect the output RF energy. For example, the controller 44 utilizes the information provided by the RF sense 43 to determine if RF energy should be outputted, adjusted or terminated. In one embodiment, the controller 44 determines if or when a predetermined current, power, and/or phase threshold has been reached or exceeded to determine when to terminate the output of RF energy. In various embodiments, the controller 44 performs a fusion or sealing process described in greater detail herein and in some embodiments the controller 44 receives the instructions, settings, or script data to perform the sealing process from data transmitted from the electrosurgical instrument or tool 20.


The RF Amplifier 42 generates high power RF energy to be passed through a connected electrosurgical instrument or tool 20. In one example, the electrosurgical instrument or tool 20 is used for fusing or sealing tissue. The RF Amplifier 42 in accordance with various embodiments is configured to convert a 100 VDC power source to a high power sinusoidal waveform with a frequency of 350 kHz. The converted power is then delivered to the connected electrosurgical instrument or tool 20. The RF Sense 43 interprets the measured AC voltage and current from the RF amplifier 42 and generates DC control signals, including voltage, current, power, and phase, that is interpreted by the controller 44.


The electrosurgical generator 10 (which includes the controller 44 and/or the RF sense 43) monitors and/or measures the RF energy being supplied to determine if it is as expected. In various embodiments, the system (e.g., the controller and/or RF sense), monitors the voltage and/or current of the RF energy to ensure the voltage and the current are above predefined threshold values. The system (e.g., the controller and/or RF sense), also monitors, measures, and/or calculates the phase and/or power of the supplied RF energy. The system (e.g., the controller and/or RF sense) ensures that the voltage, current, phase, and/or power of the supplied RF energy is within a predefined voltage, current, phase, and/or power window or range. In one embodiment, the voltage, current, phase, and/or power window are respectively delimited by a predefined maximum voltage, current, phase, and/or power and a predefined minimum voltage, current, phase, and/or power. If the voltage, current, phase, and/or power of the RF energy moves out of its respective window, an error is indicated. In one embodiment, the respective window slides or is adjusted by the system as RF energy is being supplied to seal the tissue between the jaws of the instrument. The adjustment of the respective window is to ensure that supplied RF energy is as expected. The system, in various embodiments, monitors the phase, and/or current or rate of phase, and/or current of the supplied RF energy to determine if the phase and/or current has reached or crossed a predefined phase and/or current threshold. If the phase and/or current crossing has occurred with respect to the predefined phase and/or current threshold, then the RF energy is supplied for a predefined time period before terminating.


In accordance with various embodiments, an operations engine of controller 44 enables the electrosurgical generator 10 to be configurable to accommodate different operational scenarios including but not limited to different and numerous electrosurgical instruments or tools, surgical procedures, and preferences. The operations engine receives and interprets data from an external source to specifically configure operation of the electrosurgical generator 10 based on the received data.


In accordance with various embodiments, the operations engine may receive configuration data from a database script file that is read from a memory device of the electrosurgical tool or instrument 20. The database script file defines the state logic used by the electrosurgical generator 10. Based on the state determined and measurements made by the electrosurgical generator 10, the database script file can define or set output levels as well as shutoff criteria for the electrosurgical generator 10. The database script file, in one embodiment, includes trigger events that include indications of a short condition, for example, when a measured phase is greater than 60 degrees, or an open condition, for example, when a measured current is less than 100 mA.


In accordance with various embodiments, after the dynamic voltage ramp, tissue that draws a relatively low amount of current or power is small in volume or may be already highly desiccated as shown, for example, in FIG. 9. The highly desiccated tissue can be commonly encountered in a double or repeated seal situation (e.g., when a surgeon activates the instrument to supply RF energy a second time after a first seal cycle or an already completed seal cycle without moving the instrument or positioning the instrument on different portions of the tissue or an entirely different tissue). Double or repeated seals results in an additional application of RF energy including heat and thereby increases potential eschar buildup, thermal spread, and/or adhesion. In various embodiments, the system reduces or prevents RF output with a high voltage when such repeated seals occur.


In accordance with various embodiments, the system identifies or determines a tissue's desiccation level in contact with the instrument. The system employs low levels of current or power, high levels of impedance, low phase angles, low energy delivery, and/or a lack of water vaporization (e.g., steam) during the seal cycle to identify a tissue's desiccation level. Once the desiccation level of the tissue has been identified, the RF output is reduced, such as providing RF energy for a limited time period or power level. In various embodiments, static thresholds can be used for any of these values to trigger conditions (e.g., 500 mA) and/or thresholds can be calculated during the seal cycle (e.g., 20% below a predicted maximum).


In various embodiments, the system uses one or more of these threshold values to distinguish already-sealed tissue and triggers early in the seal cycle. At the end of the seal cycle, first activations and subsequent activations can look very similar with the tissue being desiccated in both cases. However, at the beginning of the seal cycle, first activations will draw much more current or power since water is still present in the tissue (compared to subsequent seals which may not). In addition, as tissue seals, the current or power drawn can change substantially. An activation on an already-sealed tissue may have a much lower rate of change and as such, the system utilizes the derivative of measurement value of interest to be used to identify a meaningful change being made to the tissue.


In various embodiments, the system tracks phase of the RF output and in particular, at the beginning of a seal cycle, to identify repetitive seals and/or thin tissue. Double seals tend to have phase values of greater than 20 degrees. Once a repeated seal or piece of thin tissue is identified, an alternate RF path for that tissue can be applied.


In various embodiments, the system uses a cascade of phase values which adjusts the RF output depending on the magnitude of the initial phase. For example, if the phase is between 20 and 25 degrees, a modest reduction of RF energy is applied. However, if the phase is between 25 and 30 degrees, there is more certainty of the type of tissue in contact with the instrument, and thus RF energy being applied is reduced further or more aggressively. Continuing with this example, a phase angle over 30 degrees would provide the largest or most aggressive reduction in RF energy.


Once highly desiccated or thin tissue has been identified, any change in RF output that results in less heat being applied results in a better tissue sealing effects. Additional RF energy or no reduction in RF energy on this type of tissue can result in additional thermal spread, eschar, adhesion, and/or a longer procedure time without providing further benefits to hemostasis.


In accordance with various embodiments, the electrosurgical system comprising a double seal system that uses a threshold value to stop a voltage ramp, which results in in a lower hold voltage through the seal and/or uses a threshold value to terminate or halt the RF output and/or ending the seal cycle. In various embodiments, the double seal system also uses a threshold value to immediately leave a state, rather than reaching a timeout value and can result in a reduction in total seal time.


Exemplary RF energy control process, script, or systems for the electrosurgical generator and associated electrosurgical tools for fusing or sealing tissue in accordance with various embodiments are shown in FIG. 10. In a first step 71, RF energy is supplied by the electrosurgical generator through the connected electrosurgical tool. The electrosurgical generator sets the voltage of the supplied RF energy in order to generate the RF energy having a steep ramp in step 72. In accordance with various embodiments, the RF energy that is provided or generated is a steep ramp with voltage increasing from a predefined initial value (e.g., 40V) to a maximum value (e.g., 60V) in a predefined time period (e.g., 75 ms) and/or with current increasing from a predefined initial value (e.g., 2500 mA) to a predefined maximum value (e.g., 5000 mA) in the same predefined time period (e.g., 75 ms). The electrosurgical generator or system determines or identifies an RF output peak condition in step 73 while continuing to supply RF energy in the ramping fashion performed in step 72.


In various embodiments, the system monitors or measures the current and/or power of the RF output in order to determine if the current and/or power is decreasing or has reached a predefined threshold. This is performed in order to further determine if a peak condition has been reached. If a peak condition is not identified or reached, the system determines if a double seal condition is present in step 74. In various embodiments, the system monitors or measures the current of the RF output and determines if the current is decreasing or has reached a predefined current threshold to determine if a double seal condition is present or identified. If the peak condition and/or a double or repeated seal is identified, the system alters or adjust to reduce the voltage of the RF output in step 75. In various embodiments, the system causes the RF energy to ramp gradually (in step 75), increasing from a predefined initial value (e.g., 35V) to a maximum value (e.g., 45V) over a predefined time period (e.g., 500 ms).


The electrosurgical generator or system monitors, determines, or identifies a hold condition in step 76 while continuing to supply RF energy in the ramping fashion as described in step 75 (above). The electrosurgical generator or system, in various embodiments, measures, calculates, and/or monitors at least the phase, voltage, current, power, and/or change/rate thereof of the supplied RF energy. If the condition (e.g., a phase and current condition) is reached or equals, exceeds or falls below a predetermined threshold or value in step 76, the RF output is adjusted in step 77. In various embodiments, the electrosurgical generator causes the voltage of the supplied RF output to be held constant and/or the ramp terminated. In various embodiments, if a phase condition or threshold is reached or falls below a predetermined phase threshold value and a current condition or value is reached or falls below a predetermined current threshold value, the electrosurgical generator adjusts the voltage of the supplied RF energy to be constant. If the phase and current condition or threshold is not reached or crossed, the electrosurgical generator waits a predefined time period while continuing to supply RF energy in the ramping fashion (via step 75) and monitoring for the hold condition (via step 76). With constant voltage (via step 77), the electrosurgical generator monitors, identifies, or determines an end condition (via step 78) while continuing to supply and/or adjust the RF energy being supplied (in step 77). If the end condition is determined or identified, the process is characterized as being done. Termination procedures are initiated and/or RF energy supplied by the generator is stopped (in step 79). If the power condition or threshold representing the end condition is reached or equals, exceeds or falls below a predetermined threshold or value, the process is characterized as being done. Termination procedures can then be initiated and/or RF energy supplied by the generator can be stopped. If the end condition or threshold is not reached or crossed, the electrosurgical generator continues to supply RF energy, while monitoring for the power condition.


In various embodiments, prior to the start of the process, impedance is measured to determine a short condition or open condition through a low voltage measurement signal delivered to a connected electrosurgical tool. In one embodiment, passive impedance is measured to determine if the tissue grasped is within the operating range of the electrosurgical tool (e.g., 2-200Ω). If the initial impedance check is passed, the RF energy is supplied to the electrosurgical tool, after which impedance/resistance is not measured again or ignored.


In various embodiments, the maximum current or power value is static or predetermined, stored in memory, or is provided or set through external inputs. In accordance with various embodiments, the maximum current or power value is determined by the system through the application of the RF energy and monitoring the current and/or power of the supplied RF energy to determine a current or power peak. In various embodiments, the maximum current or power value represents a vaporization point for the tissue in contact with the electrosurgical instrument. In various embodiments, the generator provides a high voltage steep ramp to bring the tissue to a water vaporization point quickly.


In accordance with various embodiments, a maximum phase value is determined by the system through the application of the RF energy and monitoring the phase to determine a phase peak representing an RF output peak condition. In various embodiments, a thermocouple or similar temperature sensor or detection system is provided with the instrument, such as a thermocouple embedded on the surface of a jaw, to monitor tissue temperature and potentially identify a rapid rise of temperature occurring until water vaporization begins, at which point a state change would stop the rise in temperature due to additional heat creating steam and thus an RF output peak condition can be identified. In accordance with various embodiments, a minimum impedance is determined by the system through the application of the RF energy and monitoring the tissue impedance to determine an impedance floor representing an RF output peak floor. As such, the process or system is somewhat inverted with a minimum value or window being determined rather than a maximum.


In various embodiments, the electrosurgical generator provides a high voltage ramp or pulse to bring the tissue to a RF output peak point or condition quickly. In various embodiments, the RF output peak condition represents or corresponds to a water vaporization point or condition, e.g., when the fluid in the tissue begins to change state and vaporize. This can be observed when steam starts being generated from the tissue being sealed. This point or condition, in various embodiments, is defined or identified when the power or current output of the RF energy being applied or supplied is at its greatest or reaches its peak. If the vaporization or peak point is not reached during the pulse (e.g., under-pulsing), then the subsequent drop in voltage and gradual ramp-up is delayed in this seal cycle. Tissue that is under-pulsed starts its effective seal cycle or removal of water much later than anticipated, resulting in less total water being removed in the same time period.


In accordance with various embodiments, the electrosurgical generator is configured to provide additional regulation of various parameters or functions related to the output of the RF energy, voltage, current, power, and/or phase and the operations engine is configured to utilize the various parameters or functions to adjust the output of the RF energy. In one exemplary embodiment, the control circuitry provides additional regulation controls for direct regulation of phase in which voltage, current, and/or power output would be adjusted to satisfy specified phase regulation set points provided by the operations engine.


In accordance with various embodiments, the generator utilizes the monitored, measured and/or calculated values of voltage, power, current, and/or phase (e.g., control indicators) to recognize and act/perform operation conditions. In various embodiments, additional measurements or calculations based on the measured values related to RF output regulation circuitry are provided by the script or operations engine to recognize and act upon additional or different events related to or trigger by the additional measurements or calculations relative to other measurements or thresholds. The additional measurements in one embodiment include error signals in combination with a pulse width modulation (PWM) duty cycle used to regulate the output of voltage, current and/or power or other similar regulation parameters. Different or additional events or indicators that could be identified and triggered in various embodiments could be transitions from one regulation control to another regulation control (e.g., current regulation to power regulation). In various embodiments, subsequent impedance or temperature checks or measurements may not be performed as such checks or measurements may be imprecise and/or impractical.


In various embodiments, the generator utilizes many states, control points, or checks to identify a phase, current, or power value and respectively for a positive or negative trend. An error is signaled if the electrosurgical generator does not identify an expected trend. The multistate checks increase or enhance the electrosurgical generator resolution in identifying an expected RF output trend over different types of tissue.


In various embodiments, the electrosurgical generator also monitors the phase or current and/or rate of phase or current to determine if the connected electrosurgical tool has experienced an electrical open condition or short condition. In one example, the electrosurgical generator identifies an electrical short condition of the connected electrosurgical instrument by monitoring the phase of the applied or supplied RF energy. If the monitored phase is greater than a predefined maximum phase value, an electrical short condition is identified. Similarly, in one example, the electrosurgical generator identifies an electrical open condition of the connected electrosurgical instrument by monitoring the current of the applied or supplied RF energy. If the monitored current is less than a predefined minimum current, an electrical open condition is identified. In either or both cases, the electrosurgical generator upon discovery of the open condition and/or short condition indicates an error and the RF energy being supplied is halted.


In various embodiments, the predefined process as described throughout the application is loaded into a memory module embedded into a connector removably connected to a plug and/or cable connection to an electrosurgical instrument. In various embodiments, the device script or process is programmed onto an adapter PCBA (Printed Circuit Board Assembly) contained within the device connector or hardwired into circuitry within the device connector or controller during manufacture/assembly. The script source file is written in a custom text-based language and is then compiled by a script compiler into a script database file that is only readable by the generator. The script file contains parameters specifically chosen to configure the generator to output a specific voltage (e.g., 100v (RMS)), current (e.g., 5000 mA (RMS)), and power level (e.g., 300VA). In various embodiments, a device key programmer device reads and then programs the script database file into the memory of the adapter PCBA.


Turning now to some of the operational aspects of the electrosurgical tool or instrument described herein in accordance with various embodiments, once a vessel or tissue bundle has been identified for fusing, the first jaw 31 and the second jaw 33 are placed around the tissue. The movable handle 23 is squeezed and thereby pivots the first jaw 31 and the second jaw 33 together to effectively grasp the tissue. The actuator 24 has a first or initial position in which the jaws 22 are in an open position with the movable handle 23 positioned away or spaced from the stationary housing 28.


The depression of the activation button 29 by the surgeon causes the application of the radio frequency energy to the tissue between the jaws 22. Once the tissue has been fused, the actuator 24 can be reopened by the movable handle 23 being released and moved away from stationary housing 28. To cut tissue between the jaws 22, the user can actuate the blade trigger 25. When the blade trigger is moved proximally, a cutting blade moves distally to divide the tissue between the jaws 22. When the surgeon releases the blade trigger 25, the blade spring resets the cutting blade to its original position. In accordance with various embodiments, the actuator 24 has a cut position in which the jaws 22 are in a closed position, the movable handle 23 is closed and latched and the blade trigger 25 has been depressed advancing the cutting blade to its distal most position.


In various embodiments, an intermediate or unlatched position is provided in which the jaws 22 are in a closed or proximate position but the movable handle 23 is unlatched. As such, if the movable handle 23 is released, the movable handle 23 will return to its original or initial position. In one embodiment, the blade trigger 25 may not be activated to cut tissue between the jaws 22 but the activation button or switch 29 may be activated to fuse tissue between the jaws 22. In various embodiments, a latched position is provided in which the jaws 22 are in a closed or proximate position and the movable handle 23 is latched. As such, if the movable handle 23 is released, the movable handle 23 will not return to its original or initial position. In one embodiment, the activation button or switch 29 may be activated to fuse tissue between the closed jaws 22 and/or the blade trigger 25 may be activated to cut tissue between the jaws 22.


As described, in accordance with various embodiments, the electrosurgical instrument has a first (open) state in which the jaws 22 are spaced from each other and thus the movable handle 23 is also spaced from the stationary housing 28. The electrosurgical instrument is thus positioned to grasp tissue between the jaws 22. In the second (intermediate) state of the instrument, the jaws 22 are proximate to each other to grasp tissue between the jaws 22 and likewise the movable handle 23 and the stationary housing 28 are proximate to each other. The surgeon can revert back from the second state to the first state by opening the jaws 22 and thus positioning the jaws 22 again to grasp the tissue or other tissue. In the third (closed) state of the electrosurgical instrument, the movable handle 23 is moved further closer to the stationary housing 28. In some embodiments, the movable handle 23 may latch to the stationary housing 28. Movement to the third state, tissue grasped between the jaws 22 can be cut through the activation of the blade trigger 25. Movement to the third state, in which the movable handle 23 is latched to the stationary housing 28, reduces the potential situations whereby the tissue is unintentionally released. Also, inadvertent cutting of tissue or cutting of tissue along the wrong tissue lines can be better avoided. Additionally, the third (closed) state allows the application of constant and continuous predefined compression or range of compression on the tissue between the jaws 22 before, during, and after the activation of the RF energy, thereby enhancing the sealing or fusion of the tissue between the jaws 22. In accordance with various embodiments, application of the RF energy can occur once the mobile handle 23 and jaws 22 are in at least the second state and once the activation button 29 is activated by the surgeon. In some embodiments, the application of the RF energy can occur when the mobile handle 23 and jaws 22 are in the third state and once the activation button 29 is activated by the surgeon.


It is noted that in various embodiments to avoid false readings, the electrosurgical generator does not measure resistance or impedance of the tissue during the supply of the RF energy to the tissue. In accordance with various embodiments, an electrosurgical system is provided that decreases thermal spread and provides efficient power delivery for sealing vessels or tissue in contact with a bipolar electrosurgical instrument through the controlled and efficient supply of RF energy.


As described throughout the application, the electrosurgical generator supplies RF energy to a connected electrosurgical instrument. The electrosurgical generator ensures that the supplied RF energy does not exceed specified parameters and detects faults or error conditions. In various embodiments, an electrosurgical instrument provides the commands or logic used to appropriately apply RF energy for a surgical procedure. An electrosurgical instrument for example includes memory having commands and parameters that dictate the operation of the instrument in conjunction with the electrosurgical generator. For example, the electrosurgical generator can supply the RF energy but the connected electrosurgical instrument decides how much or how long the RF energy is applied. The electrosurgical generator, however, does not allow the supply of RF energy to exceed a set threshold even if directed to by the connected electrosurgical instrument thereby providing a check or assurance against a faulty instrument command.


As described generally above and described in further detail below, various electrosurgical instruments, tools, or devices can be used in the electrosurgical systems described herein. For example, electrosurgical graspers, scissors, tweezers, probes, needles, and other instruments incorporating one, some, or all of the aspects discussed herein can provide various advantages in an electrosurgical system. Various electrosurgical instruments and generator embodiments and combinations thereof are discussed throughout the application. It is contemplated that one, some, or all of the features discussed generally throughout the application can be included in any of the embodiments of the instruments, generators and combinations thereof discussed herein. For example, it can be desirable that each of the instruments described include a memory for interaction with the generator as previously described and vice versa. However, in other embodiments, the instruments and/or generators described can be configured to interact with a standard bipolar radio frequency power source without interaction of an instrument memory. Further, although various embodiments may be described in terms of modules and/or blocks to facilitate description, such modules and/or blocks may be implemented by one or more hardware components, e.g., processors, Digital Signal Processors (DSPs), Programmable Logic Devices (PLDs), Application Specific Integrated Circuits (ASICs), circuits, registers and/or software components, e.g., programs, subroutines, logic and/or combinations of hardware and software components. Likewise, such software components may be interchanged with hardware components or a combination thereof and vice versa.


Further examples of the electrosurgical unit, instruments and connections there between and operations and/or functionalities thereof are described in U.S. patent application Ser. No. 12/416,668, filed Apr. 1, 2009, entitled “Electrosurgical System”; Ser. No. 12/416,751, filed Apr. 1, 2009, entitled “Electrosurgical System”; Ser. No. 12/416,695, filed Apr. 1, 2009, entitled “Electrosurgical System”; Ser. No. 12/416,765, filed Apr. 1, 2009, entitled “Electrosurgical System”; Ser. No. 12/416,128, filed Mar. 31, 2009, entitled “Electrosurgical System”; and Ser. No. 14/848,116, filed Sep. 8, 2015, entitled “Electrosurgical System”; the entire disclosures of which are hereby incorporated by reference as if set in full herein. Certain aspects of these electrosurgical generators, tools and systems are discussed herein, and additional details and examples with respect to various embodiments are described in US Provisional Application Nos. 61/994,215, filed May 16, 2014, entitled “Electrosurgical Fusion Device”; 61/944,185, filed May 16, 2014, “Electrosurgical Generator with Synchronous Detector”; 61/994,415, filed May 16, 2014, “Electrosurgical System”; and 61/944,192, filed May 16, 2014, entitled “Electrosurgical Generator”, the entire disclosures of which are hereby incorporated by reference as if set in full herein.


The above description is provided to enable any person skilled in the art to make and use the surgical devices and perform the methods described herein and sets forth the best modes contemplated by the inventors of carrying out their inventions. Various modifications, however, will remain apparent to those skilled in the art. It is contemplated that these modifications are within the scope of the present disclosure. Additionally, different embodiments or aspects of such embodiments may be shown in various figures and described throughout the specification. However, it should be noted that although shown or described separately each embodiment and aspects thereof may be combined with one or more of the other embodiments and aspects thereof unless expressly stated otherwise. It is merely for easing readability of the specification that each combination is not expressly set forth. Also, embodiments of the present invention should be considered in all respects as illustrative and not restrictive.

Claims
  • 1. An electrosurgical generator for fusing or sealing tissue comprising: a controller configured to: instruct an RF amplifier to apply a first pre-determined amount of RF energy to an area of tissue,determine a desiccation level of the area of tissue affected by the applying of the first pre-determined amount of RF energy,instruct the RF amplifier to reduce the first pre-determined amount of RF energy being applied to the area of tissue to a second amount of RF energy based on the determined desiccation level,instruct the RF amplifier to increase an amount of RF energy being applied to the area of tissue from the second amount to a third amount, wherein a rate of ramping the increasing amount of RF energy being applied and the third amount of RF energy to be applied to the area of tissue are based on the determined desiccation level, and wherein the third amount is between the first amount of RF energy and the second amount of RF energy,instruct the RF amplifier to maintain the third amount of RF energy being applied to the area of tissue, andinstruct the RF amplifier to terminate the application of the RF energy to the area of the tissue after a first pre-determined period of time has elapsed; andan RF amplifier configured to generate a corresponding amount of RF energy that is passed to an electrosurgical instrument connected to the electrosurgical generator, wherein the corresponding amount of RF energy generated is based on the instructions provided by the controller.
  • 2. The electrosurgical generator of claim 1, wherein the electrosurgical instrument includes memory configured to store a script, wherein the script is downloaded from the memory of the electrosurgical instrument to the controller, and wherein the script includes instructions that configure the electrosurgical generator to generate pre- defined amounts of RF energy for the electrosurgical instrument.
  • 3. The electrosurgical generator of claim 2, wherein the first, second, and third amount of RF energy generated by the RF amplifier is also based on associated surgical procedures being performed.
  • 4. The electrosurgical generator of claim 2, wherein the first, second, and third amount of RF energy generated by the RF amplifier is also based on received user preferences, and wherein the received user preferences are obtained via user inputs associated with the electrosurgical generator.
  • 5. The electrosurgical generator of claim 1, further comprising a user interface configured to receive user input, wherein instructions are generated that instruct the electrosurgical generator to generate an amount of RF energy based on the user input.
  • 6. The electrosurgical generator of claim 1, wherein the first, second, and third amount of RF energy generated by the RF amplifier is also based on the type of electrosurgical instrument connected to the electrosurgical generator.
  • 7. The generator of claim 1, wherein the first pre-determined amount of RF energy applied to the area of tissue by the RF amplifier has lower levels of current or power.
  • 8. The generator of claim 1, wherein the first pre-determined amount of RF energy applied to the area of tissue by the RF amplifier has high levels of impedance.
  • 9. The generator of claim 1, wherein the first pre-determined amount of RF energy applied to the area of tissue by the RF amplifier has low phase angles.
  • 10. The generator of claim 1, wherein the first pre-determined amount of RF energy applied to the area of tissue by the RF amplifier has low energy delivery.
  • 11. The generator of claim 1, wherein the determining of the desiccation level of the area of tissue by the controller includes identifying a current peak condition of the RF energy being applied to the area of tissue.
  • 12. The generator of claim 11, wherein the determining of the desiccation level of the area of tissue by the controller further includes identifying that the current peak condition of the RF energy being applied to the area of tissue is less than a pre-defined threshold.
  • 13. The generator of claim 12, wherein the pre-defined threshold corresponds to a double seal condition.
  • 14. The generator of claim 12, wherein the identifying of the current peak condition includes: establishing a break value that is based on a percentage of a maximum amount or window for voltage or current that can be applied to the area of tissue; anddetecting that a current voltage or current measurement is greater than the break value.
  • 15. The generator of claim 14, wherein a difference between the first pre-determined amount of RF energy being applied to the area of tissue and the second amount of RF energy is based on the percentage used with establishing the break value.
  • 16. The generator of claim 15, wherein an amount for higher percentages associated with establishing the break value is higher than a different amount that corresponds with lower percentages associated with establishing the break value.
  • 17. The generator of claim 12, wherein the identifying of the current peak condition by the controller comprises: monitoring a rate of change of the current and/or power of the RF energy being applied to the area of tissue; andcomparing the monitored rate of change with a pre-determined threshold that corresponds to an identification that the current peak condition is near or close to occurring.
  • 18. The generator of claim 12, wherein the identifying of the current peak condition by the controller comprises: regulating current associated with the RF energy being applied to the area of tissue;detecting an increase in voltage greater than a pre-determined threshold voltage; andassociating a timing of the increase in voltage greater than the pre-determined threshold voltage with the current peak condition.
  • 19. The generator of claim 1, wherein the determining of the desiccation level of the area of tissue by the controller includes identifying an amount of water vaporization during the seal cycle.
  • 20. The generator of claim 19, wherein the amount of water vaporization is identified by the controller via an output of steam.
  • 21. The generator of claim 1, wherein the second amount of RF energy that the controller instructs the RF amplifier to reduce from the first pre-determined amount of RF energy is based on a percentage associated with a predicted maximum amount of RF energy that can be applied to the area of tissue.
  • 22. The generator of claim 1, wherein the second amount of RF energy that the controller instructs the RF amplifier to reduce from the first pre-determined amount of RF energy is a pre-set value.
  • 23. The generator of claim 1, wherein the determining of the desiccation level by the controller includes identifying situations where the area of tissue has previously been fused or sealed.
  • 24. The generator of claim 1, wherein the determining of the desiccation level by the controller includes identifying a thickness of the area of tissue.
  • 25. The generator of claim 1, wherein the determining of the desiccation level by the controller includes identifying a volume of the area of tissue.
  • 26. The generator of claim 1, wherein the first pre-determined amount of RF energy that the controller instructs the RF amplifier to apply to the area of tissue has a pre-determined slope voltage profile that corresponds to a pre-determined increase in voltage of the RF energy over a second pre-determined period of time.
  • 27. The generator of claim 26, wherein the second pre-determined period of time is based on a surface area of the area of tissue.
  • 28. The generator of claim 26, wherein the second pre-determined period of time includes a maximum time threshold that terminates the increase in voltage of the RF energy once the maximum time threshold is reached.
  • 29. The generator of claim 1, wherein the first pre-determined period of time associated with maintaining the third amount of RF energy being applied to the area of tissue is based on characteristics of the area of tissue.
  • 30. The generator of claim 29, wherein the characteristics of the area of tissue includes a thickness or a volume of the area of tissue.
  • 31. The generator of claim 1, wherein the first pre-determined amount of RF energy being applied to the area of tissue as instructed by the controller to the RF amplifier is configured to heat the area of tissue to a pre-determined temperature of 100° C. to perform desiccation.
  • 32. The generator of claim 1, wherein the third amount of RF energy applied to the area of tissue as instructed by the controller to the RF amplifier is configured to maintain a temperature of the area of tissue sufficient for continued desiccation.
  • 33. The generator of claim 1, wherein the controller further instructing the RF amplifier to increase the amount of RF energy being applied to the area of tissue from the second amount to the third amount comprises: monitoring a phase and current of the RF energy as the amount of voltage of the RF energy increases from the second amount;detecting when the current falls and when the phase becomes capacitive; andidentifying the third amount based on when the detected current fall and capacitive phase occurs.
  • 34. The generator of claim 1, wherein the controller is configured to identify the different desiccation levels for the area of tissue in order to identify associated different second and third amounts of RF energy being applied to the area of tissue and different rates of ramping the RF energy from the second and third amounts to desiccate the area of tissue.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to and benefit of U.S. Provisional Patent Application Ser. No. 62/768,782 entitled “Electrosurgical System” filed on Nov. 16, 2018, which is incorporated herein by reference in its entirety.

US Referenced Citations (1162)
Number Name Date Kind
371664 Brannan et al. Oct 1887 A
702472 Pignolet Jun 1902 A
728883 Downes May 1903 A
1586645 Bierman Jun 1926 A
1935289 Evans Nov 1933 A
2002594 Wappler et al. May 1935 A
2031682 Wappler et al. Feb 1936 A
2113246 Wappler Apr 1938 A
2176479 Willis Oct 1939 A
2305156 Grubel Dec 1942 A
2632661 Cristofv Mar 1953 A
2827056 Degelman Mar 1958 A
3085566 Tolles Apr 1963 A
3459187 Pallotta Aug 1969 A
3494363 Jackson Feb 1970 A
3588710 Masters Jun 1971 A
3651811 Hildebrandt et al. Mar 1972 A
3685518 Beuerle et al. Aug 1972 A
3780416 Rider Dec 1973 A
3826263 Cage et al. Jul 1974 A
3911766 Fridolph et al. Oct 1975 A
3920021 Hiltebrandt Nov 1975 A
3938527 Rioux et al. Feb 1976 A
3963030 Newton Jun 1976 A
3970088 Morrison Jul 1976 A
3980085 Ikuno Sep 1976 A
3987795 Morrison Oct 1976 A
4030501 Archibald Jun 1977 A
4041952 Morrison, Jr. et al. Aug 1977 A
4043342 Morrison, Jr. Aug 1977 A
4060088 Morrison, Jr. et al. Nov 1977 A
4074718 Morrison, Jr. Feb 1978 A
4089336 Cage et al. May 1978 A
4092986 Schneiderman Jun 1978 A
4094320 Newton et al. Jun 1978 A
4114623 Meinke et al. Sep 1978 A
4126137 Archibald Nov 1978 A
4154240 Ikuno et al. May 1979 A
4171700 Farin Oct 1979 A
4181131 Ogui Jan 1980 A
4188927 Harris Feb 1980 A
4196734 Harris Apr 1980 A
4198957 Cage et al. Apr 1980 A
4198960 Utsugi Apr 1980 A
4200104 Harris Apr 1980 A
4231372 Newton Nov 1980 A
4237887 Gonser Dec 1980 A
4244371 Farin Jan 1981 A
4325374 Komiya Apr 1982 A
4331149 Gonser May 1982 A
4338940 Ikuno Jul 1982 A
4352156 Gyugyi Sep 1982 A
4370980 Lottick Feb 1983 A
4416276 Newton et al. Nov 1983 A
4416277 Newton et al. Nov 1983 A
4427014 Bel et al. Jan 1984 A
4429694 McGreevy Feb 1984 A
4463759 Garito et al. Aug 1984 A
4487489 Takamatsu Dec 1984 A
4514619 Kugelman Apr 1985 A
4522206 Whipple et al. Jun 1985 A
4552143 Lottick Nov 1985 A
4569131 Faulk et al. Feb 1986 A
4569345 Manes Feb 1986 A
4590934 Malis et al. May 1986 A
4599553 Brennen et al. Jul 1986 A
4630218 Hurley Dec 1986 A
4632109 Paterson Dec 1986 A
4644950 Valli Feb 1987 A
4651280 Chang et al. Mar 1987 A
4655216 Tischer Apr 1987 A
4657018 Hakky Apr 1987 A
4658815 Farin et al. Apr 1987 A
4658819 Harris et al. Apr 1987 A
4658820 Klicek Apr 1987 A
4674498 Stasz Jun 1987 A
4685459 Koch et al. Aug 1987 A
4699146 Sieverding Oct 1987 A
4712545 Honkanen Dec 1987 A
4716897 Noguchi et al. Jan 1988 A
4727874 Bowers et al. Mar 1988 A
4739759 Rexroth et al. Apr 1988 A
4741334 Irnich May 1988 A
4752864 Clappier Jun 1988 A
4754757 Feucht Jul 1988 A
4788977 Farin et al. Dec 1988 A
4802476 Noerenberg et al. Feb 1989 A
4818954 Flachenecker et al. Apr 1989 A
4827927 Newton May 1989 A
4848335 Manes Jul 1989 A
4850353 Stasz et al. Jul 1989 A
4860745 Farin et al. Aug 1989 A
4862889 Feucht Sep 1989 A
4862890 Stasz et al. Sep 1989 A
4872456 Hasson Oct 1989 A
4887612 Esser et al. Dec 1989 A
4889722 Sheffield et al. Dec 1989 A
4903696 Stasz et al. Feb 1990 A
4905691 Rydell Mar 1990 A
4922903 Welch et al. May 1990 A
4936281 Stasz Jun 1990 A
4937254 Sheffield et al. Jun 1990 A
4938761 Ensslin Jul 1990 A
4942313 Kinzel Jul 1990 A
4958539 Stasz et al. Sep 1990 A
4969885 Farin Nov 1990 A
4976711 Parins et al. Dec 1990 A
5007908 Rydell Apr 1991 A
5013312 Parins et al. May 1991 A
5015227 Broadwin et al. May 1991 A
5016521 Haka May 1991 A
5026370 Lottick Jun 1991 A
5026371 Rydell et al. Jun 1991 A
5035696 Rydell Jul 1991 A
5038109 Goble et al. Aug 1991 A
5047026 Rydell Sep 1991 A
5047027 Rydell Sep 1991 A
5052402 Bencini et al. Oct 1991 A
5057107 Parins et al. Oct 1991 A
5061269 Muller Oct 1991 A
5062031 Flachenecker et al. Oct 1991 A
5071419 Rydell et al. Dec 1991 A
5078717 Parins et al. Jan 1992 A
5083565 Parins Jan 1992 A
5085659 Rydell Feb 1992 A
5087257 Farin et al. Feb 1992 A
5098431 Rydell Mar 1992 A
5116332 Lottick May 1992 A
5122137 Lennox Jun 1992 A
5125928 Parins et al. Jun 1992 A
5127412 Cosmetto et al. Jul 1992 A
5151102 Kamiyama et al. Sep 1992 A
5158561 Rydell et al. Oct 1992 A
5160343 Brancel et al. Nov 1992 A
5167658 Ensslin Dec 1992 A
5171255 Rydell Dec 1992 A
5171311 Rydell Dec 1992 A
5190517 Zieve et al. Mar 1993 A
5190541 Abele et al. Mar 1993 A
5192280 Parins Mar 1993 A
5197963 Parins Mar 1993 A
5197964 Parins Mar 1993 A
5201732 Parins et al. Apr 1993 A
5217457 Delahuerga et al. Jun 1993 A
5217458 Parins Jun 1993 A
5234427 Ohtomo et al. Aug 1993 A
5244462 Delahuerga et al. Sep 1993 A
5246440 Van Noord Sep 1993 A
5250047 Rydell Oct 1993 A
5250056 Hasson Oct 1993 A
5254126 Filipi et al. Oct 1993 A
5256149 Banik et al. Oct 1993 A
5258006 Rydell et al. Nov 1993 A
5267997 Farin et al. Dec 1993 A
5269780 Roos Dec 1993 A
5273524 Fox et al. Dec 1993 A
5281216 Klicek Jan 1994 A
5282799 Rydell Feb 1994 A
5286255 Weber Feb 1994 A
5290286 Parins Mar 1994 A
5300070 Gentelia et al. Apr 1994 A
5304190 Reckelhoff et al. Apr 1994 A
5312329 Beaty et al. May 1994 A
5314424 Nicholas May 1994 A
5318563 Malis et al. Jun 1994 A
5322055 Davison et al. Jun 1994 A
5324289 Eggers Jun 1994 A
5330471 Eggers Jul 1994 A
5334183 Wuchinich Aug 1994 A
5338317 Hasson et al. Aug 1994 A
5341807 Nardella Aug 1994 A
5341815 Cofone et al. Aug 1994 A
5342359 Rydell Aug 1994 A
5342381 Tidemand Aug 1994 A
5352222 Rydell Oct 1994 A
5352223 McBrayer et al. Oct 1994 A
5354313 Boebel Oct 1994 A
5356408 Rydell Oct 1994 A
5370645 Klicek et al. Dec 1994 A
5372124 Takayama et al. Dec 1994 A
5372596 Klicek et al. Dec 1994 A
5374277 Hassler Dec 1994 A
5382247 Cimino et al. Jan 1995 A
5383880 Hooven Jan 1995 A
5383922 Zipes et al. Jan 1995 A
5387196 Green et al. Feb 1995 A
5387197 Smith et al. Feb 1995 A
5389104 Hahnen et al. Feb 1995 A
5389849 Asano et al. Feb 1995 A
5391166 Eggers Feb 1995 A
5392917 Alpern et al. Feb 1995 A
5400267 Denen et al. Mar 1995 A
5403312 Yates et al. Apr 1995 A
5403342 Tovey et al. Apr 1995 A
5405344 Willaimson et al. Apr 1995 A
5409498 Braddock et al. Apr 1995 A
5417687 Nardella et al. May 1995 A
5422567 Matsunaga Jun 1995 A
5423808 Edwards et al. Jun 1995 A
5423810 Goble et al. Jun 1995 A
5431638 Hennig et al. Jul 1995 A
5431649 Mulier et al. Jul 1995 A
5431674 Basile et al. Jul 1995 A
5432459 Thompson et al. Jul 1995 A
5436566 Thompson et al. Jul 1995 A
5437664 Cohen et al. Aug 1995 A
5438302 Goble Aug 1995 A
5443463 Stern et al. Aug 1995 A
5445142 Hassler, Jr. Aug 1995 A
5445638 Rydell et al. Aug 1995 A
5447513 Davison et al. Sep 1995 A
5449355 Rhum et al. Sep 1995 A
5456684 Schmidt et al. Oct 1995 A
5458598 Feinberg et al. Oct 1995 A
5460182 Goodman et al. Oct 1995 A
5462546 Rydell Oct 1995 A
5464144 Guy et al. Nov 1995 A
5472439 Hurd Dec 1995 A
5472442 Klicek Dec 1995 A
5472443 Cordis et al. Dec 1995 A
5472451 Freitas et al. Dec 1995 A
5474057 Makower et al. Dec 1995 A
5476479 Green et al. Dec 1995 A
5478351 Meade et al. Dec 1995 A
5484400 Edwards et al. Jan 1996 A
5486185 Freitas et al. Jan 1996 A
5496312 Klicek Mar 1996 A
5496317 Goble et al. Mar 1996 A
5499992 Meade et al. Mar 1996 A
5499998 Meade et al. Mar 1996 A
5503320 Webster et al. Apr 1996 A
5507773 Huitema et al. Apr 1996 A
5509916 Taylor Apr 1996 A
5514129 Smith May 1996 A
5514134 Rydell et al. May 1996 A
5518163 Hooven May 1996 A
5518164 Hooven May 1996 A
5527313 Scott et al. Jun 1996 A
5527330 Tovey Jun 1996 A
5531744 Nardella et al. Jul 1996 A
5540681 Strul et al. Jul 1996 A
5540684 Hassler, Jr. Jul 1996 A
5540685 Parins et al. Jul 1996 A
5541376 Ladtkow et al. Jul 1996 A
5551945 Yabe et al. Sep 1996 A
5558429 Cain Sep 1996 A
5558671 Yates Sep 1996 A
5562699 Heimberger et al. Oct 1996 A
5562700 Huitema et al. Oct 1996 A
5571100 Goble et al. Nov 1996 A
5571121 Heifetz Nov 1996 A
5573424 Poppe Nov 1996 A
5573533 Strul Nov 1996 A
5573534 Stone Nov 1996 A
5573535 Viklund Nov 1996 A
5575789 Bell et al. Nov 1996 A
5575805 Li Nov 1996 A
5584830 Ladd et al. Dec 1996 A
5599344 Paterson Feb 1997 A
5599350 Schulze et al. Feb 1997 A
5603711 Parins et al. Feb 1997 A
D378611 Croley Mar 1997 S
5607391 Klinger et al. Mar 1997 A
5609151 Mulier et al. Mar 1997 A
5609560 Ichikawa et al. Mar 1997 A
5609573 Sandock Mar 1997 A
5611709 McAnulty Mar 1997 A
5613966 Makower et al. Mar 1997 A
5620415 Lucey et al. Apr 1997 A
5620447 Smith et al. Apr 1997 A
5624452 Yates Apr 1997 A
5626575 Crermer May 1997 A
5626607 Malecki et al. May 1997 A
5626608 Cuny et al. May 1997 A
5627584 Nishikori et al. May 1997 A
5633578 Eggers et al. May 1997 A
5645540 Henniges et al. Jul 1997 A
5647869 Goble et al. Jul 1997 A
5651780 Jackson et al. Jul 1997 A
5658279 Nardella et al. Aug 1997 A
5658281 Heard Aug 1997 A
5665100 Yoon Sep 1997 A
5665105 Furnish et al. Sep 1997 A
5667517 Hooven Sep 1997 A
5669907 Platt, Jr. et al. Sep 1997 A
5674184 Hassler, Jr. Oct 1997 A
5674220 Fox et al. Oct 1997 A
5683349 Makower et al. Nov 1997 A
5688270 Yates et al. Nov 1997 A
5693045 Eggers Dec 1997 A
5693051 Schulze et al. Dec 1997 A
5695494 Becker Dec 1997 A
5697281 Eggers et al. Dec 1997 A
5697909 Eggers et al. Dec 1997 A
5700261 Brinkerhoff Dec 1997 A
5702386 Stern et al. Dec 1997 A
5702387 Arts et al. Dec 1997 A
5702390 Austin et al. Dec 1997 A
5707369 Vaitekunas et al. Jan 1998 A
5709680 Yates et al. Jan 1998 A
5713128 Schrenk et al. Feb 1998 A
5713895 Lontine et al. Feb 1998 A
5713896 Nardella Feb 1998 A
5720742 Quinn et al. Feb 1998 A
5720744 Eggleston et al. Feb 1998 A
5720745 Farin et al. Feb 1998 A
5722975 Edwards et al. Mar 1998 A
5725524 Mulier et al. Mar 1998 A
5735848 Yates et al. Apr 1998 A
5735849 Baden et al. Apr 1998 A
5743456 Jones et al. Apr 1998 A
5743906 Parins et al. Apr 1998 A
5746210 Benaron et al. May 1998 A
5746740 Nicholas May 1998 A
5746759 Meade et al. May 1998 A
5752519 Benaron et al. May 1998 A
5755717 Yates et al. May 1998 A
5759185 Grinberg Jun 1998 A
5762609 Benaron et al. Jun 1998 A
5766167 Eggers et al. Jun 1998 A
5769791 Benaron et al. Jun 1998 A
5769841 Odell et al. Jun 1998 A
5772597 Goldberger et al. Jun 1998 A
5772659 Becker et al. Jun 1998 A
5772660 Young et al. Jun 1998 A
5776092 Farin et al. Jul 1998 A
5776129 Mersch Jul 1998 A
5776130 Buysse et al. Jul 1998 A
5776155 Beaupre et al. Jul 1998 A
5782397 Koukline Jul 1998 A
5785658 Benaron et al. Jul 1998 A
5792139 Chambers et al. Aug 1998 A
5792178 Welch et al. Aug 1998 A
5797906 Rhum et al. Aug 1998 A
5797938 Paraschac et al. Aug 1998 A
5797941 Schulze et al. Aug 1998 A
5800449 Wales Sep 1998 A
5807261 Benaron et al. Sep 1998 A
5807393 Williamson, IV et al. Sep 1998 A
5807395 Mulier et al. Sep 1998 A
5810806 Ritchart et al. Sep 1998 A
5810811 Yates et al. Sep 1998 A
5810859 DiMatteo et al. Sep 1998 A
5817091 Nardella et al. Oct 1998 A
5817093 Williamson, IV et al. Oct 1998 A
5817119 Klieman et al. Oct 1998 A
5827271 Buysse et al. Oct 1998 A
5827279 Hughett et al. Oct 1998 A
5827299 Thomason et al. Oct 1998 A
5830231 Geiges, Jr. Nov 1998 A
5833690 Yates et al. Nov 1998 A
5836942 Netherly et al. Nov 1998 A
5836943 Miller, III Nov 1998 A
5846194 Wasson et al. Dec 1998 A
5849020 Long et al. Dec 1998 A
5853412 Mayenberger Dec 1998 A
5860975 Goble et al. Jan 1999 A
5873873 Smith et al. Feb 1999 A
5876398 Mulier et al. Mar 1999 A
5876401 Schulze et al. Mar 1999 A
5885277 Korth Mar 1999 A
5891095 Eggers et al. Apr 1999 A
5891141 Rydell Apr 1999 A
5891142 Eggers et al. Apr 1999 A
5893835 Witt et al. Apr 1999 A
5893873 Rader et al. Apr 1999 A
5897490 Fox et al. Apr 1999 A
5897523 Wright et al. Apr 1999 A
5897553 Mulier et al. Apr 1999 A
5897569 Kellogg et al. Apr 1999 A
5902264 Toso et al. May 1999 A
5902301 Olig May 1999 A
5904709 Arndt et al. May 1999 A
5906613 Mulier et al. May 1999 A
5908402 Blythe Jun 1999 A
5908420 Parins et al. Jun 1999 A
5910152 Bays Jun 1999 A
5928137 Green Jul 1999 A
5928255 Meade et al. Jul 1999 A
5928256 Riza Jul 1999 A
5931836 Hatta et al. Aug 1999 A
5935126 Riza Aug 1999 A
5938633 Beaupre Aug 1999 A
5944715 Goble et al. Aug 1999 A
5944718 Austin et al. Aug 1999 A
5944737 Tsonton et al. Aug 1999 A
5947284 Foster Sep 1999 A
5947984 Whipple Sep 1999 A
5951552 Long et al. Sep 1999 A
5954736 Bishop et al. Sep 1999 A
5954746 Holthaus et al. Sep 1999 A
5957943 Vaitekunas Sep 1999 A
5961514 Long et al. Oct 1999 A
5968062 Thomas et al. Oct 1999 A
5968074 Prestel Oct 1999 A
5976077 Wittens et al. Nov 1999 A
5976128 Schilling et al. Nov 1999 A
5980510 Tsonton et al. Nov 1999 A
5980516 Mulier et al. Nov 1999 A
5984921 Long et al. Nov 1999 A
5987346 Benaron et al. Nov 1999 A
5993380 Yabe et al. Nov 1999 A
5993447 Blewett et al. Nov 1999 A
5995875 Blewett et al. Nov 1999 A
5997533 Kuhns Dec 1999 A
6003517 Sheffield et al. Dec 1999 A
6004319 Goble et al. Dec 1999 A
6004335 Vaitekunas et al. Dec 1999 A
6010499 Cobb Jan 2000 A
6010516 Hulka Jan 2000 A
6013076 Goble et al. Jan 2000 A
6015406 Goble et al. Jan 2000 A
6016809 Mulier et al. Jan 2000 A
D420741 Croley Feb 2000 S
6024741 Williamson, IV et al. Feb 2000 A
6024744 Kese et al. Feb 2000 A
6027501 Goble et al. Feb 2000 A
6027522 Palmer Feb 2000 A
6030384 Nezhat Feb 2000 A
6030402 Thompson et al. Feb 2000 A
6033399 Gines Mar 2000 A
6033404 Melzer et al. Mar 2000 A
6036657 Milliman et al. Mar 2000 A
6039733 Buysse et al. Mar 2000 A
6039734 Goble Mar 2000 A
6039736 Platt, Jr. Mar 2000 A
6050996 Schmaltz et al. Apr 2000 A
6051010 DiMatteo et al. Apr 2000 A
6053172 Hovda et al. Apr 2000 A
6053914 Eggers et al. Apr 2000 A
6056746 Goble et al. May 2000 A
6063050 Manna et al. May 2000 A
6063075 Mihori May 2000 A
6063081 Mulier et al. May 2000 A
6063086 Benecke et al. May 2000 A
6066139 Ryan et al. May 2000 A
6068627 Orszulak et al. May 2000 A
6068647 Witt et al. May 2000 A
6070444 Lontine et al. Jun 2000 A
6074386 Goble et al. Jun 2000 A
RE36795 Rydell Jul 2000 E
6083191 Rose Jul 2000 A
6086586 Hooven Jul 2000 A
6090106 Goble et al. Jul 2000 A
6090120 Wright et al. Jul 2000 A
6092722 Heinrichs et al. Jul 2000 A
6093186 Goble Jul 2000 A
6096037 Mulier et al. Aug 2000 A
6102909 Chen et al. Aug 2000 A
6106521 Blewett et al. Aug 2000 A
6109268 Thapliyal et al. Aug 2000 A
6110171 Rydell Aug 2000 A
6113591 Whayne et al. Sep 2000 A
6113594 Savage Sep 2000 A
6113596 Hooven et al. Sep 2000 A
6113598 Baker Sep 2000 A
6117152 Huitema Sep 2000 A
6120501 Long et al. Sep 2000 A
H1904 Yates Oct 2000 H
6132429 Baker Oct 2000 A
6135998 Palanker Oct 2000 A
6139519 Blythe Oct 2000 A
6139547 Lontine et al. Oct 2000 A
6142992 Cheng et al. Nov 2000 A
6152923 Ryan Nov 2000 A
6159146 El Gazayerli Dec 2000 A
6162235 Vaitekunas Dec 2000 A
6165175 Wampler et al. Dec 2000 A
6168605 Measamer et al. Jan 2001 B1
6171304 Netherly et al. Jan 2001 B1
6174308 Goble et al. Jan 2001 B1
6174309 Wrublewski et al. Jan 2001 B1
6179834 Buysse et al. Jan 2001 B1
6186147 Cobb Feb 2001 B1
6187003 Buysse et al. Feb 2001 B1
6187026 Devlin et al. Feb 2001 B1
6190383 Schmaltz et al. Feb 2001 B1
6190385 Tom et al. Feb 2001 B1
6190386 Rydell Feb 2001 B1
6193129 Bittner et al. Feb 2001 B1
6193653 Evans et al. Feb 2001 B1
6193713 Geistert et al. Feb 2001 B1
6197026 Farin et al. Mar 2001 B1
6203541 Keppel Mar 2001 B1
6206823 Kolata et al. Mar 2001 B1
6206844 Reichel et al. Mar 2001 B1
6206875 Long et al. Mar 2001 B1
6206877 Kese et al. Mar 2001 B1
6210403 Klicek Apr 2001 B1
6210405 Goble et al. Apr 2001 B1
6214003 Morgan et al. Apr 2001 B1
6214023 Whipple et al. Apr 2001 B1
6228023 Zaslavsky et al. May 2001 B1
6228055 Foerster et al. May 2001 B1
6228080 Gines May 2001 B1
6228081 Goble May 2001 B1
6228083 Lands et al. May 2001 B1
6234178 Goble et al. May 2001 B1
6237604 Burnside et al. May 2001 B1
6238366 Savage et al. May 2001 B1
6238392 Long May 2001 B1
6238393 Mulier et al. May 2001 B1
6242741 Miller et al. Jun 2001 B1
6246912 Sluijter et al. Jun 2001 B1
6251106 Becker et al. Jun 2001 B1
6251110 Wampler Jun 2001 B1
6254623 Haibel, Jr. et al. Jul 2001 B1
6257241 Wampler Jul 2001 B1
6258085 Eggleston Jul 2001 B1
6261286 Goble et al. Jul 2001 B1
6267761 Ryan Jul 2001 B1
6270497 Sekino et al. Aug 2001 B1
6273862 Privitera et al. Aug 2001 B1
6277114 Bullivant et al. Aug 2001 B1
6277115 Saadat Aug 2001 B1
6277117 Tetzlaff et al. Aug 2001 B1
6280398 Ritchart et al. Aug 2001 B1
6280407 Manna et al. Aug 2001 B1
6280441 Ryan Aug 2001 B1
6283963 Regula Sep 2001 B1
6287344 Wampler Sep 2001 B1
6293942 Goble et al. Sep 2001 B1
6293945 Parins et al. Sep 2001 B1
6296637 Thorne et al. Oct 2001 B1
6296640 Wampler et al. Oct 2001 B1
6298550 Kirwan, Jr. Oct 2001 B1
6302903 Mulier et al. Oct 2001 B1
6306131 Hareyama et al. Oct 2001 B1
6306134 Goble et al. Oct 2001 B1
6308089 von der Ruhr et al. Oct 2001 B1
6309400 Beaupre Oct 2001 B2
6312426 Goldberg et al. Nov 2001 B1
6315777 Comben Nov 2001 B1
6319221 Savage et al. Nov 2001 B1
6322494 Bullivant et al. Nov 2001 B1
6322549 Eggers et al. Nov 2001 B1
6322561 Eggers et al. Nov 2001 B1
6325795 Lindemann et al. Dec 2001 B1
6325799 Goble Dec 2001 B1
6325811 Messerly Dec 2001 B1
6328736 Mulier et al. Dec 2001 B1
6328751 Beaupre Dec 2001 B1
6331181 Tierney et al. Dec 2001 B1
6334068 Hacker Dec 2001 B1
6334861 Chandler et al. Jan 2002 B1
6336926 Goble Jan 2002 B1
6348051 Farin et al. Feb 2002 B1
6352532 Kramer et al. Mar 2002 B1
6352536 Buysse et al. Mar 2002 B1
6358248 Mulier et al. Mar 2002 B1
6358249 Chen et al. Mar 2002 B1
6358267 Murakami Mar 2002 B1
6361534 Chen et al. Mar 2002 B1
6364877 Goble et al. Apr 2002 B1
6364879 Chen et al. Apr 2002 B1
6371967 Long et al. Apr 2002 B1
D457958 Dycus et al. May 2002 S
6383183 Sekino et al. May 2002 B1
6387092 Burnside et al. May 2002 B1
6387109 Davison et al. May 2002 B1
6391024 Sun et al. May 2002 B1
6391025 Weinstein et al. May 2002 B1
6398779 Buysse et al. Jun 2002 B1
6398781 Goble et al. Jun 2002 B1
6402741 Keppel et al. Jun 2002 B1
6402742 Blewett et al. Jun 2002 B1
6402743 Orszulak et al. Jun 2002 B1
6402747 Lindemann et al. Jun 2002 B1
6402748 Schoenman et al. Jun 2002 B1
6406475 Wenzler et al. Jun 2002 B1
6409722 Hoey et al. Jun 2002 B1
6409724 Penny et al. Jun 2002 B1
6409728 Ehr et al. Jun 2002 B1
6416486 Wampler Jul 2002 B1
6416509 Goble et al. Jul 2002 B1
6423057 He et al. Jul 2002 B1
6423082 Houser et al. Jul 2002 B1
6432118 Messerly Aug 2002 B1
6436096 Hareyama Aug 2002 B1
6440130 Mulier et al. Aug 2002 B1
6443952 Mulier et al. Sep 2002 B1
6443968 Holthaus et al. Sep 2002 B1
6443970 Schulze et al. Sep 2002 B1
6451013 Bays et al. Sep 2002 B1
6451018 Lands et al. Sep 2002 B1
6454764 Fleenor et al. Sep 2002 B1
6454781 Witt et al. Sep 2002 B1
6454782 Schwemberger Sep 2002 B1
6458078 Lüdtke et al. Oct 2002 B1
6458128 Schulze Oct 2002 B1
6458130 Frazier et al. Oct 2002 B1
6458142 Faller et al. Oct 2002 B1
6461352 Morgan et al. Oct 2002 B2
6464689 Qin et al. Oct 2002 B1
6464702 Schulze et al. Oct 2002 B2
6464704 Schmaltz et al. Oct 2002 B2
6468275 Wampler et al. Oct 2002 B1
6468286 Mastri et al. Oct 2002 B2
6475217 Platt Nov 2002 B1
6478030 Shapeton et al. Nov 2002 B1
6482202 Goble et al. Nov 2002 B1
6485490 Wampler et al. Nov 2002 B2
6488507 Stoloff et al. Dec 2002 B1
6488680 Francischelli et al. Dec 2002 B1
6491690 Goble et al. Dec 2002 B1
6491708 Madan et al. Dec 2002 B2
6493589 Medhkour et al. Dec 2002 B1
6494877 Odell et al. Dec 2002 B2
6494902 Hoey et al. Dec 2002 B2
6497705 Comben Dec 2002 B2
6500176 Truckai et al. Dec 2002 B1
6500188 Harper et al. Dec 2002 B2
6503263 Adams Jan 2003 B2
6506189 Rittman, III et al. Jan 2003 B1
6506208 Hunt et al. Jan 2003 B2
6510854 Goble et al. Jan 2003 B2
6511476 Hareyama Jan 2003 B2
6511480 Tetzlaff et al. Jan 2003 B1
6514252 Nezhat et al. Feb 2003 B2
6517536 Hooven et al. Feb 2003 B2
6517538 Jacob et al. Feb 2003 B1
6526320 Mitchell Feb 2003 B2
6527771 Weadock et al. Mar 2003 B1
6533784 Truckai et al. Mar 2003 B2
6534770 Miller et al. Mar 2003 B2
6537248 Mulier et al. Mar 2003 B2
6537272 Christopherson et al. Mar 2003 B2
6540695 Burbank et al. Apr 2003 B1
6543456 Freeman Apr 2003 B1
6547783 Vilendrer et al. Apr 2003 B1
6547786 Goble et al. Apr 2003 B1
6554829 Schulze et al. Apr 2003 B2
6558379 Batchelor et al. May 2003 B1
6558383 Cunningham et al. May 2003 B2
6561983 Cronin et al. May 2003 B2
6562037 Paton et al. May 2003 B2
6565559 Eggleston May 2003 B2
6565560 Goble et al. May 2003 B1
6569105 Kortenbach et al. May 2003 B1
6569109 Sakurai et al. May 2003 B2
6572615 Schulze et al. Jun 2003 B2
6579289 Schnitzler Jun 2003 B2
6582424 Fleenor et al. Jun 2003 B2
6582427 Goble et al. Jun 2003 B1
6584360 Francischelli et al. Jun 2003 B2
D477408 Bromley Jul 2003 S
6585732 Mulier et al. Jul 2003 B2
6585733 Wellman Jul 2003 B2
6585735 Frazier et al. Jul 2003 B1
6589200 Schwemberger et al. Jul 2003 B1
6591719 Poole et al. Jul 2003 B1
6592582 Hess et al. Jul 2003 B2
6594518 Benaron et al. Jul 2003 B1
6602227 Cimino et al. Aug 2003 B1
6602249 Stoddard et al. Aug 2003 B1
6602252 Mollenauer Aug 2003 B2
6605036 Wild Aug 2003 B1
6607529 Jones et al. Aug 2003 B1
6610060 Mulier et al. Aug 2003 B2
6611793 Burnside et al. Aug 2003 B1
6613048 Mulier et al. Sep 2003 B2
6616656 Brommersma Sep 2003 B2
6616660 Platt Sep 2003 B1
6616661 Wellman et al. Sep 2003 B2
6620157 Dabney et al. Sep 2003 B1
6620161 Schulze et al. Sep 2003 B2
6623482 Pendekanti et al. Sep 2003 B2
6623515 Mulier et al. Sep 2003 B2
6626901 Treat et al. Sep 2003 B1
6629974 Penny et al. Oct 2003 B2
6638274 Yamamoto Oct 2003 B2
6648883 Francischelli et al. Nov 2003 B2
6652514 Ellman et al. Nov 2003 B2
6652521 Schulze Nov 2003 B2
6656110 Irion et al. Dec 2003 B1
6656175 Francischelli et al. Dec 2003 B2
6656176 Hess et al. Dec 2003 B2
6656177 Truckai et al. Dec 2003 B2
6660017 Beaupre Dec 2003 B2
6662050 Olson Dec 2003 B2
6662127 Wiener et al. Dec 2003 B2
6663622 Foley et al. Dec 2003 B1
6663627 Francischelli et al. Dec 2003 B2
6663628 Peters Dec 2003 B2
6666865 Platt Dec 2003 B2
6676660 Wampler et al. Jan 2004 B2
6678621 Wiener et al. Jan 2004 B2
6679882 Kornerup Jan 2004 B1
6682527 Strul Jan 2004 B2
6682528 Frazier et al. Jan 2004 B2
6682544 Mastri et al. Jan 2004 B2
6685701 Orszulak et al. Feb 2004 B2
6685703 Pearson et al. Feb 2004 B2
6692450 Coleman Feb 2004 B1
6692489 Heim et al. Feb 2004 B1
6695837 Howell Feb 2004 B2
6695838 Wellman et al. Feb 2004 B2
6695840 Schulze Feb 2004 B2
6699240 Francischelli Mar 2004 B2
6706038 Francischelli et al. Mar 2004 B2
6706039 Mulier et al. Mar 2004 B2
6709432 Ferek-Petric Mar 2004 B2
6723091 Goble et al. Apr 2004 B2
6726683 Shaw Apr 2004 B1
6726686 Buysse et al. Apr 2004 B2
6733498 Paton et al. May 2004 B2
6736810 Hoey et al. May 2004 B2
6740084 Ryan May 2004 B2
6740085 Hareyama et al. May 2004 B2
6740102 Hess et al. May 2004 B2
6743229 Buysse et al. Jun 2004 B2
6752804 Simpson et al. Jun 2004 B2
6755825 Schoenman et al. Jun 2004 B2
6755827 Mulier et al. Jun 2004 B2
6755841 Fraser et al. Jun 2004 B2
6758846 Goble et al. Jul 2004 B2
6764487 Mulier et al. Jul 2004 B2
6770071 Woloszko et al. Aug 2004 B2
6770072 Truckai et al. Aug 2004 B1
6773409 Truckai et al. Aug 2004 B2
6773434 Ciarrocca Aug 2004 B2
6773435 Schulze et al. Aug 2004 B2
6773444 Messerly Aug 2004 B2
6775575 Bommannan et al. Aug 2004 B2
6776780 Mulier et al. Aug 2004 B2
6780180 Goble et al. Aug 2004 B1
6786906 Cobb Sep 2004 B1
6790217 Schulze et al. Sep 2004 B2
6796828 Ehr et al. Sep 2004 B2
6796981 Wham et al. Sep 2004 B2
6807444 Tu et al. Oct 2004 B2
6807968 Francischelli et al. Oct 2004 B2
6808518 Wellman et al. Oct 2004 B2
6808525 Latterell et al. Oct 2004 B2
6814745 Prestel Nov 2004 B2
6821273 Mollenauer Nov 2004 B2
6827715 Francischelli et al. Dec 2004 B2
6827717 Brommersma et al. Dec 2004 B2
6827725 Batchelor et al. Dec 2004 B2
6830569 Thompson et al. Dec 2004 B2
6832111 Tu et al. Dec 2004 B2
6832985 Irion et al. Dec 2004 B2
6832998 Goble Dec 2004 B2
6835082 Gonnering Dec 2004 B2
6835195 Schulze et al. Dec 2004 B2
6837887 Woloszko et al. Jan 2005 B2
6843789 Goble Jan 2005 B2
6849073 Hoey et al. Feb 2005 B2
6852112 Platt Feb 2005 B2
6855142 Harano et al. Feb 2005 B2
6855145 Ciarrocca Feb 2005 B2
6858028 Mulier et al. Feb 2005 B2
6860881 Sturm et al. Mar 2005 B2
6860894 Pittman Mar 2005 B1
6887240 Lands et al. May 2005 B1
6889694 Hooven May 2005 B2
6893435 Goble May 2005 B2
6893441 Brommersma et al. May 2005 B2
6899710 Hooven May 2005 B2
6905497 Truckai et al. Jun 2005 B2
6905498 Hooven Jun 2005 B2
6908472 Wiener et al. Jun 2005 B2
6911019 Mulier et al. Jun 2005 B2
6913579 Truckai et al. Jul 2005 B2
6916318 Francischelli et al. Jul 2005 B2
6918880 Brookner et al. Jul 2005 B2
6923803 Goble Aug 2005 B2
6923804 Eggers et al. Aug 2005 B2
6923806 Hooven et al. Aug 2005 B2
6926716 Baker et al. Aug 2005 B2
6929641 Goble et al. Aug 2005 B2
6929644 Truckai et al. Aug 2005 B2
6932810 Ryan Aug 2005 B2
6932811 Hooven et al. Aug 2005 B2
6937033 Boronkay et al. Aug 2005 B2
6939347 Thompson Sep 2005 B2
6942660 Pantera et al. Sep 2005 B2
6942662 Goble et al. Sep 2005 B2
6945972 Frigg et al. Sep 2005 B2
6945981 Donofrio et al. Sep 2005 B2
6948503 Refior et al. Sep 2005 B2
6949098 Mulier et al. Sep 2005 B2
6958063 Soil et al. Oct 2005 B1
6960209 Clague et al. Nov 2005 B2
6960210 Lands et al. Nov 2005 B2
6962587 Johnson et al. Nov 2005 B2
6962589 Mulier et al. Nov 2005 B2
6966907 Goble Nov 2005 B2
6966909 Marshall et al. Nov 2005 B2
6971988 Orban, III Dec 2005 B2
6974453 Woloszko et al. Dec 2005 B2
6974454 Hooven Dec 2005 B2
6976969 Messerly Dec 2005 B2
6979332 Adams Dec 2005 B2
6984231 Goble et al. Jan 2006 B2
6984233 Hooven Jan 2006 B2
6984826 Miller et al. Jan 2006 B2
6989010 Francischelli et al. Jan 2006 B2
6994705 Nobis et al. Feb 2006 B2
6997735 Ehr et al. Feb 2006 B2
6997935 Anderson et al. Feb 2006 B2
7001380 Goble Feb 2006 B2
7001415 Hooven Feb 2006 B2
7011657 Truckai et al. Mar 2006 B2
7025764 Paton et al. Apr 2006 B2
7029470 Francischelli et al. Apr 2006 B2
7033351 Howell Apr 2006 B2
7033354 Keppel Apr 2006 B2
7033356 Latterell et al. Apr 2006 B2
7041096 Malis et al. May 2006 B2
7041102 Truckai et al. May 2006 B2
7044948 Keppel May 2006 B2
7044949 Orszulak et al. May 2006 B2
7044950 Yamamoto May 2006 B2
7048687 Reuss et al. May 2006 B1
7049599 Miller et al. May 2006 B2
7052494 Goble et al. May 2006 B2
7060063 Marion et al. Jun 2006 B2
7063699 Hess et al. Jun 2006 B2
7066933 Hagg Jun 2006 B2
7066936 Ryan Jun 2006 B2
7070597 Truckai et al. Jul 2006 B2
7074218 Washington et al. Jul 2006 B2
7074219 Levine et al. Jul 2006 B2
7083618 Couture et al. Aug 2006 B2
7083619 Truckai et al. Aug 2006 B2
7083620 Jahns et al. Aug 2006 B2
7087054 Truckai et al. Aug 2006 B2
7090673 Dycus et al. Aug 2006 B2
7094202 Nobis et al. Aug 2006 B2
7094235 Francischelli Aug 2006 B2
7097644 Long Aug 2006 B2
7101371 Dycus et al. Sep 2006 B2
7101372 Dycus et al. Sep 2006 B2
7101373 Dycus et al. Sep 2006 B2
7103947 Sartor et al. Sep 2006 B2
7104834 Robinson et al. Sep 2006 B2
7104989 Skarda Sep 2006 B2
7108695 Witt et al. Sep 2006 B2
7111769 Wales et al. Sep 2006 B2
7112201 Truckai et al. Sep 2006 B2
RE39358 Goble Oct 2006 E
7116157 Ross et al. Oct 2006 B2
7118564 Ritchie et al. Oct 2006 B2
7118570 Tetzlaff et al. Oct 2006 B2
7118587 Dycus et al. Oct 2006 B2
7119516 Denning Oct 2006 B2
7124932 Isaacson Oct 2006 B2
7125409 Truckai et al. Oct 2006 B2
7126125 Miller et al. Oct 2006 B2
7131445 Amoah Nov 2006 B2
7131860 Sartor et al. Nov 2006 B2
7131970 Moses et al. Nov 2006 B2
7131971 Dycus et al. Nov 2006 B2
7135018 Ryan et al. Nov 2006 B2
7135020 Lawes et al. Nov 2006 B2
7137980 Buysse et al. Nov 2006 B2
D533942 Kerr et al. Dec 2006 S
7147635 Ciarrocca Dec 2006 B2
7147637 Goble Dec 2006 B2
7147638 Chapman et al. Dec 2006 B2
7150097 Sremcich et al. Dec 2006 B2
7150748 Ebbutt et al. Dec 2006 B2
7150749 Dycus et al. Dec 2006 B2
7153300 Goble Dec 2006 B2
7156843 Skarda Jan 2007 B2
7156845 Mulier et al. Jan 2007 B2
7156846 Dycus et al. Jan 2007 B2
7159750 Racenet et al. Jan 2007 B2
7160293 Sturm et al. Jan 2007 B2
7160298 Lawes et al. Jan 2007 B2
7160299 Baily Jan 2007 B2
7163548 Stulen et al. Jan 2007 B2
7166105 Mulier et al. Jan 2007 B2
7169115 Nobis et al. Jan 2007 B2
7169144 Hoey et al. Jan 2007 B2
7169145 Isaacson et al. Jan 2007 B2
7169146 Truckai et al. Jan 2007 B2
7172591 Harano et al. Feb 2007 B2
7179254 Pendkanti et al. Feb 2007 B2
7179258 Buysse et al. Feb 2007 B2
7182604 Ehr et al. Feb 2007 B2
7186252 Nobis et al. Mar 2007 B2
7186253 Truckai et al. Mar 2007 B2
7187790 Sabol et al. Mar 2007 B2
7189231 Clague et al. Mar 2007 B2
7189232 Scholl et al. Mar 2007 B2
7189233 Truckai et al. Mar 2007 B2
7191015 Lamson et al. Mar 2007 B2
7195627 Amoah et al. Mar 2007 B2
7195630 Ciarrocca Mar 2007 B2
7195631 Dumbauld Mar 2007 B2
7204835 Latterell et al. Apr 2007 B2
7207471 Heinrich et al. Apr 2007 B2
7207990 Lands et al. Apr 2007 B2
D541938 Kerr et al. May 2007 S
7211081 Goble May 2007 B2
7211084 Goble et al. May 2007 B2
7214224 Goble May 2007 B2
7216001 Hacker et al. May 2007 B2
7220260 Fleming et al. May 2007 B2
7220951 Truckai et al. May 2007 B2
7223239 Schulze et al. May 2007 B2
7223265 Keppel May 2007 B2
7226447 Uchida et al. Jun 2007 B2
7229307 Ehr et al. Jun 2007 B2
7232439 Ciarrocca Jun 2007 B2
7232440 Dumbald et al. Jun 2007 B2
7235048 Rein et al. Jun 2007 B2
7235072 Sartor et al. Jun 2007 B2
7235073 Levine et al. Jun 2007 B2
7237708 Guy et al. Jul 2007 B1
7241296 Buysse et al. Jul 2007 B2
7247141 Makin et al. Jul 2007 B2
7247155 Hoey et al. Jul 2007 B2
7250048 Francischelli et al. Jul 2007 B2
7250051 Francischelli Jul 2007 B2
7252667 Moses et al. Aug 2007 B2
7255694 Keppel Aug 2007 B2
7255696 Goble et al. Aug 2007 B2
7255697 Dycus et al. Aug 2007 B2
7259340 Blaha et al. Aug 2007 B2
7261711 Mulier et al. Aug 2007 B2
7267677 Johnson et al. Sep 2007 B2
7270660 Ryan Sep 2007 B2
7270664 Johnson et al. Sep 2007 B2
7273483 Weiner et al. Sep 2007 B2
7276068 Johnson et al. Oct 2007 B2
7278994 Goble Oct 2007 B2
7282048 Goble et al. Oct 2007 B2
7282049 Oraszulak et al. Oct 2007 B2
7291161 Hooven Nov 2007 B2
7297145 Woloszko et al. Nov 2007 B2
7300435 Wham et al. Nov 2007 B2
7300446 Beaupre Nov 2007 B2
7300450 Vleugels et al. Nov 2007 B2
7303557 Wham et al. Dec 2007 B2
7309325 Mulier et al. Dec 2007 B2
7309849 Truckai et al. Dec 2007 B2
7311560 Ehr et al. Dec 2007 B2
7311706 Schoenman et al. Dec 2007 B2
7311707 Hagg et al. Dec 2007 B2
7311709 Truckai et al. Dec 2007 B2
7322975 Goble et al. Jan 2008 B2
7329256 Johnson et al. Feb 2008 B2
7335997 Weiner Feb 2008 B2
7344532 Goble et al. Mar 2008 B2
7347858 Francischelli et al. Mar 2008 B2
RE40279 Sluijter et al. Apr 2008 E
D567943 Moses et al. Apr 2008 S
7353068 Tanaka et al. Apr 2008 B2
7354435 Farin et al. Apr 2008 B2
7354440 Truckai et al. Apr 2008 B2
7354443 Moll et al. Apr 2008 B2
7364577 Wham et al. Apr 2008 B2
7364578 Francischelli et al. Apr 2008 B2
7364579 Mulier et al. Apr 2008 B2
7367972 Francischelli et al. May 2008 B2
7367976 Lawes et al. May 2008 B2
7371246 Viola May 2008 B2
7377902 Burbank et al. May 2008 B2
7377918 Amoah May 2008 B2
7377920 Buysse et al. May 2008 B2
RE40388 Gines Jun 2008 E
7381209 Truckai et al. Jun 2008 B2
7384420 Dycus et al. Jun 2008 B2
7384421 Hushka Jun 2008 B2
7396336 Orszulak et al. Jul 2008 B2
D575395 Hushka Aug 2008 S
D575401 Hixson et al. Aug 2008 S
7416101 Shelton, IV et al. Aug 2008 B2
7416437 Sartor et al. Aug 2008 B2
7419487 Johnson et al. Sep 2008 B2
7422139 Shelton, IV et al. Sep 2008 B2
7422588 Mulier et al. Sep 2008 B2
7424965 Racenet et al. Sep 2008 B2
7425835 Eisele Sep 2008 B2
7426415 Kühner Sep 2008 B2
7431720 Pendekanti et al. Oct 2008 B2
7431721 Paton et al. Oct 2008 B2
7435249 Buysse et al. Oct 2008 B2
7435250 Francischelli et al. Oct 2008 B2
7442167 Dunki-Jacobs et al. Oct 2008 B2
7442193 Shields et al. Oct 2008 B2
7442194 Dumbauld et al. Oct 2008 B2
7445621 Dumbauld et al. Nov 2008 B2
7458972 Keppel Dec 2008 B2
7464846 Shelton, IV et al. Dec 2008 B2
7470272 Mulier et al. Dec 2008 B2
7473250 Makin et al. Jan 2009 B2
7473253 Dycus et al. Jan 2009 B2
7476233 Wiener et al. Jan 2009 B1
7481808 Koyfman et al. Jan 2009 B2
7491199 Goble Feb 2009 B2
7497858 Chapelon et al. Mar 2009 B2
7811283 Moses et al. Oct 2010 B2
7841765 Keller Nov 2010 B2
8561615 Pannell et al. Oct 2013 B2
8784417 Hanna Jul 2014 B2
8808288 Rescheke Aug 2014 B2
9161813 Benamou Oct 2015 B2
20010037110 Schmaltz et al. Nov 2001 A1
20010039417 Harano et al. Nov 2001 A1
20020052599 Goble May 2002 A1
20020115997 Truckai et al. Aug 2002 A1
20020120262 Bek et al. Aug 2002 A1
20020120266 Truckai et al. Aug 2002 A1
20020128650 McClurken Sep 2002 A1
20020151884 Hoey et al. Oct 2002 A1
20020161363 Fodor et al. Oct 2002 A1
20020165541 Whitman Nov 2002 A1
20020188294 Couture et al. Dec 2002 A1
20030004510 Wham et al. Jan 2003 A1
20030014052 Buysse et al. Jan 2003 A1
20030060818 Kannenberg et al. Mar 2003 A1
20030065327 Wellman et al. Apr 2003 A1
20030065358 Frecker et al. Apr 2003 A1
20030069571 Treat et al. Apr 2003 A1
20030109871 Johnson et al. Jun 2003 A1
20030114845 Paton et al. Jun 2003 A1
20030114848 Cobb Jun 2003 A1
20030114851 Truckai et al. Jun 2003 A1
20030125728 Nezhat et al. Jul 2003 A1
20030125731 Smith et al. Jul 2003 A1
20030125734 Mollenauer Jul 2003 A1
20030139741 Goble et al. Jul 2003 A1
20030181910 Dycus et al. Sep 2003 A1
20030199863 Swanson et al. Oct 2003 A1
20030199870 Truckai et al. Oct 2003 A1
20030229344 Dycus et al. Dec 2003 A1
20030236549 Bonadio et al. Dec 2003 A1
20040006340 Latterell et al. Jan 2004 A1
20040010289 Biggs et al. Jan 2004 A1
20040068274 Hooven Apr 2004 A1
20040068304 Paton et al. Apr 2004 A1
20040073247 Loshakove et al. Apr 2004 A1
20040082946 Malis et al. Apr 2004 A1
20040092922 Kadziauskas et al. May 2004 A1
20040122423 Dycus et al. Jun 2004 A1
20040162557 Tetzlaff et al. Aug 2004 A1
20040193148 Wham et al. Sep 2004 A1
20040215127 Kadziauskas et al. Oct 2004 A1
20040225288 Buysse et al. Nov 2004 A1
20040250419 Sremich et al. Dec 2004 A1
20050004563 Racz et al. Jan 2005 A1
20050004564 Wham et al. Jan 2005 A1
20050015125 Mioduski et al. Jan 2005 A1
20050021027 Shields et al. Jan 2005 A1
20050033282 Hooven Feb 2005 A1
20050033352 Zepf et al. Feb 2005 A1
20050080319 Dinkler, II et al. Apr 2005 A1
20050090815 Francischelli et al. Apr 2005 A1
20050096681 Desinger et al. May 2005 A1
20050101951 Wham et al. May 2005 A1
20050107785 Dycus et al. May 2005 A1
20050113817 Isaacson et al. May 2005 A1
20050113819 Wham et al. May 2005 A1
20050124915 Eggers et al. Jun 2005 A1
20050124987 Goble Jun 2005 A1
20050137592 Nguyen et al. Jun 2005 A1
20050149017 Dycus Jul 2005 A1
20050159745 Truckai et al. Jul 2005 A1
20050165444 Hart et al. Jul 2005 A1
20050192568 Truckai et al. Sep 2005 A1
20050203504 Wham et al. Sep 2005 A1
20050234447 Paton et al. Oct 2005 A1
20050245918 Sliwa, Jr. et al. Nov 2005 A1
20050245922 Goble Nov 2005 A1
20060020265 Ryan Jan 2006 A1
20060041254 Francischelli et al. Feb 2006 A1
20060052777 Dumbauld Mar 2006 A1
20060079788 Anderson et al. Apr 2006 A1
20060079878 Houser Apr 2006 A1
20060129146 Dycus et al. Jun 2006 A1
20060161190 Gadberry et al. Jul 2006 A1
20060167450 Johnson et al. Jul 2006 A1
20060173453 Gruhl et al. Aug 2006 A1
20060217697 Lau et al. Sep 2006 A1
20060217706 Lau et al. Sep 2006 A1
20060217707 Daniel et al. Sep 2006 A1
20060224152 Behnke et al. Oct 2006 A1
20060224158 Odom et al. Oct 2006 A1
20060247498 Bonadio et al. Nov 2006 A1
20060271042 Latterell et al. Nov 2006 A1
20070016185 Tullis et al. Jan 2007 A1
20070043352 Garrison et al. Feb 2007 A1
20070043353 Dycus et al. Feb 2007 A1
20070062017 Dycus et al. Mar 2007 A1
20070088202 Albrecht et al. Apr 2007 A1
20070090788 Hansford et al. Apr 2007 A1
20070093800 Wham et al. Apr 2007 A1
20070123847 Mihori May 2007 A1
20070135811 Hooven Jun 2007 A1
20070142833 Dycus et al. Jun 2007 A1
20070142834 Dumbauld Jun 2007 A1
20070156139 Schecter et al. Jul 2007 A1
20070156140 Baily Jul 2007 A1
20070167941 Hamel et al. Jul 2007 A1
20070173811 Couture et al. Jul 2007 A1
20070173813 Odom Jul 2007 A1
20070173814 Hixson et al. Jul 2007 A1
20070179499 Garrison Aug 2007 A1
20070191827 Lischinsky et al. Aug 2007 A1
20070191828 Houser et al. Aug 2007 A1
20070203481 Gregg et al. Aug 2007 A1
20070213712 Buysse et al. Sep 2007 A1
20070260242 Dycus et al. Nov 2007 A1
20070276363 Patton et al. Nov 2007 A1
20070282195 Masini et al. Dec 2007 A1
20070282320 Buysse et al. Dec 2007 A1
20070282332 Witt et al. Dec 2007 A1
20070287997 Tolmei Dec 2007 A1
20080009860 Odom Jan 2008 A1
20080015563 Hoey et al. Jan 2008 A1
20080015564 Wham et al. Jan 2008 A1
20080015567 Kimura Jan 2008 A1
20080030206 Podhajsky et al. Feb 2008 A1
20080039831 Odom et al. Feb 2008 A1
20080045947 Johnson et al. Feb 2008 A1
20080058802 Couture et al. Mar 2008 A1
20080082098 Tanaka et al. Apr 2008 A1
20080091189 Carlton Apr 2008 A1
20080114356 Johnson et al. May 2008 A1
20080125772 Stone et al. May 2008 A1
20080132893 D+ Amelio et al. Jun 2008 A1
20080167651 Tetzlaff et al. Jul 2008 A1
20080172048 Martin et al. Jul 2008 A1
20080188848 Deutmeyer et al. Aug 2008 A1
20080208246 Livneh Aug 2008 A1
20080215050 Bakos Sep 2008 A1
20080215051 Buysse et al. Sep 2008 A1
20080221565 Eder et al. Sep 2008 A1
20080228179 Eder et al. Sep 2008 A1
20080294222 Schecter Nov 2008 A1
20080300589 Paul et al. Dec 2008 A1
20080300590 Horne et al. Dec 2008 A1
20080300591 Darian et al. Dec 2008 A1
20090012520 Hixson et al. Jan 2009 A1
20090024126 Artale et al. Jan 2009 A1
20090171352 Sutter Jul 2009 A1
20090248007 Falkenstein et al. Oct 2009 A1
20090275490 Milne et al. Nov 2009 A1
20090275940 Malackowski et al. Nov 2009 A1
20120010614 Couture Jan 2012 A1
20120059371 Anderson et al. Mar 2012 A1
20120083785 Roy et al. Apr 2012 A1
20120136347 Brustad et al. May 2012 A1
20120197243 Sherman et al. Aug 2012 A1
20120215220 Manzo et al. Aug 2012 A1
20130018411 Collings et al. Jan 2013 A1
20130138101 Kerr May 2013 A1
20130138102 Twomey et al. May 2013 A1
20130197874 Heckel Aug 2013 A1
20130267951 Twomey Oct 2013 A1
20130274743 Banfalvi Oct 2013 A1
20130296843 Boudrequx et al. Nov 2013 A1
20130345696 Behnke, II et al. Dec 2013 A1
20140005658 Rosenbegr Jan 2014 A1
20140088583 Singh Mar 2014 A1
20140214019 Baxter, III et al. Jul 2014 A1
20160310203 Gaspredes et al. Oct 2016 A1
20160310204 Mchenry Oct 2016 A1
Foreign Referenced Citations (68)
Number Date Country
40 24 636 Feb 1992 DE
40 24 636 Dec 1992 DE
10 2005 044 918 Feb 2007 DE
0 315 338 May 1989 EP
0 538 984 Apr 1993 EP
0 570 675 Nov 1993 EP
0 598 202 May 1994 EP
0 717 967 Jun 1996 EP
0 737 447 Oct 1996 EP
0 878 168 Nov 1998 EP
1 054 637 Nov 2000 EP
1 157 666 Nov 2001 EP
1 500 378 Jan 2005 EP
1 535 581 Jun 2005 EP
1 545 361 Jun 2005 EP
1 557 129 Jul 2005 EP
1 634 539 Mar 2006 EP
1 634 539 Mar 2006 EP
1 665 995 Jun 2006 EP
1 728 475 Dec 2006 EP
1 810 628 Jul 2007 EP
1 946 715 Jul 2008 EP
2 106 762 Oct 2009 EP
2 111 812 Oct 2009 EP
2 156 802 Feb 2010 EP
2 301 462 Mar 2011 EP
2 340 792 Jul 2011 EP
2 436 327 Apr 2012 EP
2 436 330 Apr 2012 EP
2 574 300 Apr 2013 EP
2 712 568 Apr 2014 EP
2 777 578 Sep 2014 EP
3 369 392 Sep 2018 EP
2 157 175 Oct 1985 GB
2 462 453 Aug 2008 GB
60-30946 Feb 1994 JP
83-17935 Dec 1996 JP
11-070123 Mar 1999 JP
11-070124 Mar 1999 JP
11-178833 Jul 1999 JP
2000-254135 Sep 2000 JP
2003-135481 May 2003 JP
2003-164463 Jun 2003 JP
2006-109945 Apr 2006 JP
2006-167403 Jun 2006 JP
2007-144201 Jun 2007 JP
2007-195980 Aug 2007 JP
2007-195985 Aug 2007 JP
2008-043789 Feb 2008 JP
2008-259864 Oct 2008 JP
WO 93015662 Aug 1993 WO
WO 97010764 Mar 1997 WO
WO 99040857 Aug 1999 WO
WO 01012090 Feb 2001 WO
WO 2004030553 Apr 2004 WO
WO 2004032776 Apr 2004 WO
WO 2004032777 Apr 2004 WO
WO 2004082495 Sep 2004 WO
WO 2005004735 Jan 2005 WO
WO 05053785 Jun 2005 WO
WO 2006119245 Nov 2006 WO
WO 2006125558 Nov 2006 WO
WO 2007044849 Apr 2007 WO
WO 2007142601 Dec 2007 WO
WO 2008147773 Dec 2008 WO
WO 2009065140 May 2009 WO
WO 2012110996 Aug 2012 WO
WO 2013030349 Mar 2013 WO
Non-Patent Literature Citations (41)
Entry
European Patent Office, Extended European Search Report for European Application No. EP 21215386.0, dated May 24, 2022, 6 pgs.
International Preliminary Examining Authority/US, International Preliminaiy Report on Patentability for International Application No. PCT/US2019/059909, titled “Electrosurgical System,” dated May 27, 2021, 15 pgs.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US2019/049768 titled “Electrosurgical Generator Verification System,” dated Dec. 11, 2019, 19 pgs.
European Patent Office, Invitation to Pay Additional Fees for International Application No. PCT/US2019/049807, titled “Electrosurgical Generator Control System”, mailed Dec. 19, 2019, 16 pgs.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US2019/059909 titled “Electrosurgical System,” dated Apr. 28, 2020, 23 pgs.
European Patent Office, Extended European Search Report for European Patent No. 19198318.8, entitled, “Bipolar Electrosurgical Sealer and Divider,” dated Dec. 17, 2019, 10 pgs.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US2019/049807 titled “Electrosurgical Generator Control System,” dated Feb. 12, 2020, 20 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US2019/049768, titled “Electrosurgical Generator Verification System,” dated Mar. 18, 2021, 13 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US2019/049807, titled “Electrosurgical Generator Control System,” dated Mar. 18, 2021, 13 pgs.
Bertil Vallfors and Bjorn Bergdahl, Automatically controlled bipolar electrocoagulation—“COA-COMP”, Neurosurg. Rev., 1984, pp. 187-190.
“New Products” Journal of Medical Engineering and Technology, vol. 19, No. 5 (Sep./Oct. 1995), pp. 189-190.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US09/39046 titled “Electrosurgical System,” dated Jul. 27, 2009, 31 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US09/39046, titled “Electrosurgical System,” dated Mar. 26, 2010, 18 pgs.
European Patent Office, European Search Report for European Application No. EP 10 19 2593, titled “Electrosurgical System,” dated Mar. 21, 2011, 8 pgs.
European Patent Office, European Search Report for European Application No. EP 10 19 2614, titled “Electrosurgical System,” dated Apr. 18, 2011, 7 pgs.
European Patent Office, Extended European Search Report for European Application No. EP 10 19 2580, dated Jul. 21, 2011, 6 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US09/39046, titled “Electrosurgical System,” dated Jan. 17, 2012, 45 pgs.
European Patent Office, European Search Report for European Patent Application No. 12151288, dated Feb. 10, 2012, 8 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2011/054661, dated Mar. 6, 2012, 23 pgs.
European Patent Office, Supplementary European Search Report for European Patent Application No. 08755322, dated Apr. 18, 2012, 3 pgs.
European Patent Office, Supplementary European Search Report for European Patent Application No. 08755322, dated Jun. 6, 2012, 2 pgs.
European Patent Office, Partial European Search Report for European Patent Application No. 15151398.3, dated Jun. 22, 2015, 9 pgs.
U.S. Appl. No. 12/611,352, filed Nov. 3, 2009, titled Tissue Fusion/Welder Apparatus and Method, now U.S. Pat. No. 8,551,089 issued Oct. 8, 2013.
U.S. Appl. No. 12/183,970, filed Jul. 31, 2008, entitled Bipolar Electrosurgical Scissors, now U.S. Pat. No. 8,226,649 issued Jul. 24, 2012.
U.S. Appl. No. 12/416,128, filed Mar. 31, 2009, entitled Electrosurgical System, now U.S. Pat. No. 8,568,411 issued Oct. 29, 2013.
U.S. Appl. No. PCT/US09/39046, filed Mar. 31, 2009, entitled Electrosurgical System.
U.S. Appl. No. 12/416,668, filed Apr. 1, 2009, entitled Electrosurgical System, now U.S. Pat. No. 8,562,598 issued Oct. 22, 2013.
U.S. Appl. No. 12/416,695, filed Apr. 1, 2009, entitled Electrosurgical System, now U.S. Pat. No. 8,551,088 issued Oct. 8, 2013.
U.S. Appl. No. 12/416,765, filed Apr. 1, 2009, entitled Electrosurgical System, now U.S. Pat. No. 8,915,910 issued Dec. 23, 2014.
U.S. Appl. No. 12/416,751, filed Apr. 1, 2009, entitled Electrosurgical System, now U.S. Pat. No. 8,579,894 issued Nov. 12, 2013.
The International Bureau of WIPO, The International Preliminary Report on Patentability for International Application No. PCT/US2011/054661, entitled “Electrosurgical Instruments and Connections Thereto,” dated Apr. 2, 2013, 10 pgs.
European Patent Office, European Search Report for European Application No. EP 13 17 4814.7, titled “Electrosurgical System,” dated Sep. 30, 2013, 4 pgs.
European Patent Office, European Search Report for European Patent Application No. EP 14199708.0, entitled “Electrosurgical System,” dated Jul. 10, 2015, 14 pgs.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US2015/031452,titled “Electrosurgical Fusion Device,” dated Dec. 3, 2015, 27 pgs.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US2015/066473 titled “Bipolar Electrosurgical Sealer and Divider,” dated Mar. 31, 2016, 13 pgs.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US2015/033546 titled “Electrosurgical Seal and Dissection Systems,” dated Apr. 22, 2016, 31 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US2015/031452, titled “Electrosurgical System,” dated Dec. 1, 2016, 21 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US2015/033546, titled “Electrosurgical Laparoscopic Sealer and Dissector,” dated Dec. 15, 2016, 22 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US2015/0066473, titled “Bipolar Electrosurgical Sealer and Divider,” dated Jul. 6, 2017, 10 pgs.
European Patent Office, Extended European Search Report for European Application No. EP 17207793.5, dated May 16, 2018, 9 pgs.
European Patent Office, Extended European Search Report for European Application No. EP 18165110.0, dated Jun. 13, 2018, 6 pgs.
Related Publications (1)
Number Date Country
20200155220 A1 May 2020 US
Provisional Applications (1)
Number Date Country
62768782 Nov 2018 US